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ABSTRACT
These studies examined the role o f micelle fatty acid composition, contaminant 
body burden, biotransformation, and non-specific toxicity on the systemic bioavailabil­
ity o f 3,4,3\ 4 ’-tetrachlorobiphenyl (TCB) from the intestine of catfish, as well as the 
effect of TCB upon the vectorial transporter p-glycoprotein (pgp). Initial in vitro 
experiments demonstrated that the solubility o f  [l4C]-TCB in micelles was favored by 
longer chain fatty acids, with higher [l4C]-TCB solubility correlating to greater sys­
temic bioavailability of [l4C]-TCB in an in situ preparation. The systemic 
bioavailability o f [l4C]-TCB was demonstrated to be affected by in vivo exposures to 
TCB, in a dose-independent manner, and apparently unrelated to P4501A-related 
induction or [14C]-TCB metabolism. The latter was detectable, but quantitatively a 
minor event. Bioavailability decreases in TCB-treated animals resulted from a 
combination of lowered [14C]-TCB transport to the blood, and retention in the lumen, 
which was consistent with permeability changes resulting from toxicity, or most likely, 
alterations in [l4C]-TCB gradients resulting from unlabeled TCB accumulation in the 
tissues. Dietary pretreatment with the prototypic CYP1A inducer P-naphthoflavone 
(BNF) confirmed the lack of effect of intestinal AHH activity induction on the 
systemic bioavailability of [l4C]-TCB. Histological alterations seen with BNF 
exposures, indistinguishable from those seen with TCB, did not appear to influence 
[14C]-TCB bioavailability. These latter findings reinforced the assumptions that the 
effect of TCB preexposure on the subsequent bioavailability o f [ I4C]-TCB is 
diffusion-related. The pgp-related transporter identified in the catfish intestine was not
xi
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inducible by dietary exposures to the P4501A inducers TCB, BNF, benzo(a)pyrene, or 
the pgp inducer vincristine, under the conditions examined. In addition, functional 
analysis demonstrated that catfish pgp may exhibit some classic MDR transport 
abilities. These studies suggest that TCB intestinal biovailability can be modulated by 
micelle fatty acid composition, as well as TCB exposure history. First-pass intestinal 
metabolism appears to be an evident, but minor event in the biotransformation of 
dietary TCB. Furthermore, studies with catfish pgp suggested that induction of 
CYP1A and pgp appear to be unrelated events in the catfish intestine.
xii
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INTRODUCTION
Anthropogenic contaminants are found in many o f the world ecosystems. Since 
seventy percent o f the globe’s surface is covered with water, and land areas are washed 
by water, a great portion o f the environmental load o f contaminants is distributed to 
aquatic environments. Organisms living in those environments are exposed to 
contaminants, and are in turn consumed by humans. Aquatic species may accumulate 
xenobiotics by various routes. The relative importance of each route of exposure is 
mostly associated with the nature o f  the chemical. The dietary route of exposure is 
often most important for relatively nonpolar compounds, and the toxicity and residue 
implications of these compounds are tied to compound bioavailability and processing 
by the intestine. Polychlorinated biphenyls (PCBs) are lipophilic pollutants widely 
distributed in aquatic ecosystems (Kalmaz and Kalmaz, 1979; Tanabe, 1988; Fowler, 
1990) which accumulate in aquatic species and undergo food chain biomagnification 
(Thomann and Connolly, 1984; Connolly, 1991). 3,4,3’,4’-Tetrachlorobiphenyl (TCB) 
is an important component of PCB commercial mixtures with respect to toxicity and 
environmental distribution. The abundance of TCB in tissues o f higher organisms 
suggests that this compound may be subjected to dietary transfer.
The exact mechanism of lipophilic xenobiotic uptake in the gastrointestinal 
tract is not fully understood, but evidence indicates that it may be associated with 
movement of dietary lipids (Vetter et al., 1985; Van Veld, 1990). Lipid soluble 
compounds released from the diet are believed to associate with micelles formed by 
bile salt solubilization of dietary lipids, in order to move through the aqueous luminal
l
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environment, and reach the absorptive epithelium. Studies have suggested that the 
incorporation o f commercial PBC mixtures into lipid micelles is dependent on their 
fatty acid composition (Laher and Barrowman, 1983). It remains to be determined 
whether constituent fatty acids would similarly affect the micellar solubilization o f 
individual PCB congeners, such as TCB, or whether or not the solubilization in 
micelles would influence chemical delivery to, and through, the intestinal wall.
Once in the intestinal mucosa, PCBs may be metabolized before being trans­
ferred to the systemic circulation. The initial oxidative metabolism o f PCBs is 
mediated by the cytochrome P450 enzyme system. Recent studies with TCB have 
provided evidence that this compound may be a substrate for P4501A (CYP1A) 
hepatic metabolism in fish species (White et al., 1997), in addition to being an Ah 
(aryl hydrocarbon) agonist, and effecting CYP1A induction in a number o f fish species 
(Monosson and Stegeman, 1991; Wirgin et al., 1992; Lindstrom-Seppa et al., 1994; 
Sleiderink and Boon, 1996; Otto et al., 1997). Most research on the reciprocal 
interaction o f TCB and CYP1 A, however, have focused on the liver, and much is to be 
learned regarding the interactions o f PCBs with monooxygenases o f  other organs, 
including the gastrointestinal tract.
Intestinal biotransformation often, but not always, results in the formation of 
more polar products, which may differ from the parent compound on its rate of 
transfer to the blood. The modulatory effect o f  intestinal biotransformation on 
systemic bioavailability of xenobiotics has been recently examined in fish, using the 
polycyclic aromatic hydrocarbon benzo(a)pyrene (BaP) (Kleinow et al., 1998). These
2
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
earlier studies indicated that CYPlA-dependent intestinal metabolism, inducible by 
Ah receptor agonists, substantially affected both the extent and the composition of 
absorbed BaP. The impact of induction o f intestinal biotransformation on the systemic 
uptake of chemicals such as PCBs has not been investigated in fish species to date.
Another feature recently recognized as a major modulator of intestinal 
bioavailability of orally administered compounds is transport by the membrane-bound 
p-glycoprotein (pgp) (Lown et al., 1997; Sparreboom et al., 1997; van Asperen et al., 
1997). Active secretion by pgp prevents systemic absorption o f  drugs through active 
efflux back to the intestinal lumen (Hsing et al., 1992; Saitoh and Aungst, 1995). 
Studies in our laboratory (Kleinow et al., 2000), as well as others (Hemmer et al., 
1995), indicate that pgp is a prominent feature in the fish intestine. Broad overlap in 
substrate and inhibitor specificities indicate that pgp may act in coordination with, or 
complimentary to cytochrome P450 enzymes, in a protective mechanism against 
toxicity (Burt and Thorgeirsson, 1988; Salphati and Benet, 1998; Tateishi et al., 1999). 
Environmental pollutants containing CYP1A inducers (e.g. Diesel-2 oil) have been 
shown to modulate pgp-related transport in aquatic species. Likewise, evidence has 
been provided that lipophilic environmental contaminants, such as BaP, may be 
substrates for pgp transport (Yeh et al., 1992; Penny and Campbell, 1994). Regional 
disposition of BaP, demonstrated in the catfish intestine (Kleinow et al., 1996), 
suggests that pgp may play a modulatory role in the intestinal uptake o f contaminants 
that are CYP1A inducers (e.g. TCB, BaP) in this fish species.
3
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The overall objective of these studies was to investigate factors which would, 
alone or in combination, modulate the systemic bioavailability o f the lipophilic 
contaminant TCB from the intestine of the channel catfish. Included among the factors 
examined herein were luminal lipid micelle composition, contaminant body burdens, 
intestinal biotransformation, non-specific toxicity, and the vectorial action o f the 
transporter p-glycoprotein in the intestine.
The first hypothesis examined was that fatty acid composition determines the 
solubility o f TCB in lipid micelles, and modulates the extent of TCB systemic biovail- 
ability from the catfish intestine. The second hypothesis was that exposures to the Ah 
receptor agonists TCB and P-naphthoflavone (BNF) decrease the systemic bioavail­
ability of TCB from the catfish intestine, in a dose-dependent manner, through 
increases in intestinal cytochrome P450-dependent biotransformation, contaminant 
body burden, and non-specific toxicity. The third hypothesis was that expression and 
activity of intestinal p-glycoprotein are inducible by the Ah agonists TCB, BNF and 
BaP, with a potential role in lipophilic xenobiotic bioavailability.
In order to address these questions, specific objectives of these studies were:
1. To examine the effects o f alterations in fatty acid composition on (1) the in vitro 
solubility of [UC]-TCB in lipid micelles, and (2) the intestinal bioavailability of 
[I4C]-TCB in an in situ  preparation.
2. To investigate the effect o f TCB body burden, resulting from 10-day in vivo dietary 
exposures, on subsequent intestinal bioavailability and biotransformation o f [I4C]- 
TCB.
4
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3. To investigate the effects o f  in vivo dietary exposures to TCB and BNF on intesti­
nal integrity, using histological analysis.
4. To examine the effects o f alterations o f intestinal metabolic status, resulting from 
in vivo dietary exposure to TCB and BNF on subsequent intestinal [14C]-TCB 
bioavailability and biotransformation in an in situ preparation.
5. To assess the effect o f  in vivo dietary exposures to the CYP1A inducers TCB, BaP 
and BNF, and the pgp inducer vincristine (VIN), on pgp-related immunoreactivity 
in the catfish intestine using immunoblot analysis.
6. To elucidate the pgp-related transport capabilities of intestinal membrane vesicles 
collected from the intestine of controls, and BNF- and VIN-treated catfish, using 
the prototypic pgp substrate vinblastine, and the inhibitor verapamil.
The first chapter o f  this dissertation provides a literature overview of the distri­
bution, food chain transfer, and biotransformation of polychlorinated biphenyls in 
aquatic systems, as well as a discussion o f  factors that would modulate their intestinal 
bioavailability. The second chapter investigates both issues associated with micelle 
lipid composition, as well as TCB in vivo exposure, in relation to the in situ intestinal 
biotransformation and systemic bioavailability of [14C]-TCB. The third chapter 
provides an account o f the effects o f BNF in vivo exposure on the systemic 
bioavailability of [l4C]-TCB using an in situ  intestinal preparation. The fourth chapter 
examines the inducibility o f pgp by Ah agonists, as well as the functional abilities of 
this protein, in context with their role in intestinal bioavailability. The fifth chapter 
provides an overall summary and general conclusions.
5
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CHAPTER Is LITERATURE REVIEW  
POLYCHLORINATED BIPHENYLS 
PROPERTIES, USAGE, AND ENVIRONMENTAL DISTRIBUTION
Polychlorinated biphenyls (PCBs) are a collection o f  209 synthetic congeners 
and isomers produced by the chlorination of biphenyl, using iron filings or ferric 
chloride as catalysts (Hutzinger et al., 1974; Brinkman and de Kok, 1980). The empiri­
cal formula o f PCBs is C ^H iO -n^ln  (n = 1"10), and the conventional numbering and 
positional nomenclature o f the central structure are depicted in Figure 1.1.
The industrial production o f PCB mixtures began in the late 1920s in the 
U.S.A, and spread to industrial countries worldwide. Commercial PCBs were mar­
keted under various trade names, including Aroclor (Monsanto, U.S.A. and Great 
Britain), Clophen (Bayer, Germany), Kanechlor (Kanegafuchi, Japan), Phenochlor or 
Pyralene (Prodelec, France), and Fenclor (Caffaro, Italy). Although 209 congeners 
exist, approximately 100 individual isomers can be found in all commercial mixtures, 
each containing from 40 to 70 different compounds (Pomerantz et al., 1978; Brinkman 
and de Kok, 1980; Rappe and Buser, 1980). The commercial PCB mixtures are 
identified according to their degree o f chlorination. For example, the commercial 
Aroclor is identified by a four digit number, where the first two numbers designate the 
biphenyl structure, and the last two digits denote the percentage o f chlorine content by 
weight.
The physicochemical properties o f PCBs are associated with their degree and 
position of chlorination (Hutzinger et al., 1974; Pomerantz et al., 1978; Safe, 1994).
9
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Figure 1.1- (A) Numbering and (B) positional nomenclature of biphenyl.
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Lower chlorinated mixtures (e.g. Aroclor 1221, 1232, 1242, and 1248) are crystalline, 
mobile oils, while higher chlorinated ones (e.g. Aroclor 1254, 1260, 1262) are viscous 
or sticky resins (Hutzinger et al., 1974; Brinkman and de Kok, 1980). Such differences 
in physical properties illustrate the diversity o f PCBs, which lead to the numerous 
industrial applications (Brinkman and de Kok, 1980). The high chemical stability 
made PCBs ideal as plasticizers in rubbers and resins, one of their main open-ended 
uses. Dielectric features suited PCBs for electric insulators in transformers and 
capacitors, the latter representing the single largest PCB application. Chemical 
stability along with low vapor pressure qualified PCBs as perfect lubricants, heat- 
transfer fluids, hydraulic fluids, cutting oils and vacuum pump oils. Additionally, 
PCBs were used as adhesives, flame retardants (in polyethylene, polystyrene, and 
polyurethanes), employed as protective coating for swimming pools and maritime 
equipment, and incorporated into pesticides, dust inhibitors, immersion oils for 
microscopes, carbonless copy paper, ink, and packaging materials.
Some of the commercial applications o f PCBs resulted in the direct contamina­
tion of the environment (for example, by agricultural run-off), and industrial careless 
disposal practices or unintentional leakage further increased their environmental bur­
den (Kalmaz and Kalmaz, 1979; Kimbrough, 1980; Safe et al., 1987). The first report 
o f PCBs detection in environmental samples was by Jensen (1966), a Swedish scien­
tist, who discovered several unknown peaks while quantitating DDT using gas 
chromatography. A few years later, the health effects of PCBs went public with the 
Yusho incident, a mass food poisoning caused by ingestion o f PCB contaminated rice
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that occurred in Japan (Kuratsune, 1980). Since then, numerous studies have shown 
that PCBs can be found in most compartments o f the environment (water, air, soil, 
sediments and biota) in various regions of the world (Kalmaz and Kalmaz, 1979; 
Kimbrough, 1980; Tanabe, 1988; Fowler, 1990), and a lot o f attention has been paid 
regarding human and wildlife toxicity by PCBs (Mayer et al., 1977; Sleight, 1983; 
Safe, 1984; Parkinson and Safe, 1987).
It has been estimated that approximately 1.2 million metric tons of PCBs have 
been produced globally from the late 1920s until their production was terminated in 
the 1970s (Tanabe, 1985; Hansen, 1987). Of the total PCB production, nearly one third 
appears to be distributed in the environment, where the same chemical properties (high 
chemical stability, resistance to degradation, etc.) that favored their wide industrial use 
result in the extended persistence o f PCBs. Approximately 97% of the total 
environmental load are distributed in aquatic ecosystems (Tanabe, 1985; Hansen, 
1987), in association with the large area encompassed by world waters. For example, 
the Great Lakes account for 95% of the total surface freshwater o f  the U.S. A, and it is 
responsible for over 97% of the country’s aquatic PCB (Hansen, 1987). A compilation 
of global PCB concentrations has shown that PCBs are mostly distributed in the 
Northern hemisphere, with high concentrations in coastal areas, probably a reflection 
of industrial development (Tanabe and Tatsukawa, 1986; Fowler, 1990).
AQUATIC FOOD CHAIN TRANSFER 
In both open ocean and coastal areas, PCBs in water tend to accumulate in the 
surface microlayer, because of its higher concentration o f  lipids. Limited information
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is available regarding the concentration of PCBs in open ocean sediments, but data 
from coastal areas indicate that PCBs accumulation in sediments are dependent on 
location and sediment physiochemical characteristics (Segar and Davis, 1984; Fowler, 
1990). PCBs in surface waters and sediments may be taken up by a number o f aquatic 
species, including phytoplankton and benthic species. Phytoplankton play an important 
role in pelagic food chains, and bioconcentration (direct uptake from the water) of 
PCBs have been shown to occur in these species (Harding Jr and Phillips Jr, 1978; 
Brown et al., 1982). Benthic organisms in contact with contaminated sediments have 
been shown to bioaccumulate PCBs (through direct contact or ingestion o f sediments) 
and have been included in a number of models examining their food chain transfer 
(Oliver and Niimi, 1988; Connolly, 1991; Iannuzzi et al., 1996). Independent of the 
pathway by which PCBs enter the food web, they may progress along the various 
trophic levels, ultimately reaching humans.
Higher levels of PCBs have been found in top predators, suggesting that these 
compounds undergo biomagnification along the food chain (Mayer et al., 1977; Ras­
mussen et al., 1990). Biomagnification refers to the increases in tissue residues of 
those chemicals taken up by the animals, with progression through one or more trophic 
levels of the food chain. The relative contribution of dietary routes o f  xenobiotic 
exposure over direct uptake from the water to the overall biomagnification of PCBs 
has been a matter of debate over the years. Studies with a number of organochlorines 
have implied that tissue accumulation can be explained exclusively by direct partition 
between water and tissues (Scura and Theilacker, 1977; Macek et al., 1979;
13
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Ellgehausen et al., 1980; Bruggeman et al., 1981; Shaw and Connell, 1984). Increased 
xenobiotic accumulation in top predators was attributed to the relative lipid content of 
these organisms. For that reason, the correlation of the bioconcentration factor (BCF) 
(constant of proportionality between the concentration of chemical in the fish and in 
the water) and the octanol-water partition coefficient (KoW) (a measure of the lipophilic 
properties of a chemical), was examined by many authors. It was suggested that the 
Kow values could be used to predict the bioconcentration potential of those chemicals 
with log Kow up to 6, but not for higher Kow values (Hamelink et al., 1971; Neely, 
1979; Veithetal., 1979).
Contrasting studies in Lake Ontario ecosystems have shown that increases in 
total PCB tissue concentrations with increases in trophic levels greatly surpassed those 
expected by bioconcentration alone, indicating that diet is a major contaminant source 
(Mackay, 1982; Oliver and Niimi, 1988). In these studies, a greater divergence from 
the BCF-Kow line was seen with each trophic level, independent from tissue lipid con­
tent. Additional evidence supporting the role of dietary exposure in the overall 
biomagnification of PCBs in aquatic food chains has been provided by several authors 
(Bruggeman et al., 1984; Thomann and Connolly, 1984; Thomann, 1989). Mechanistic 
studies utilizing variables such as the uptake efficiency from the water, assimilation 
efficiency from the food, and excretion rates have suggested that food chain exposure 
can account for 90 to 99% o f contaminant accumulation in Lake Michigan lake trout 
(Thomann and Connolly, 1984; Thomann, 1989). Likewise, studies by Bruggeman et
14
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al. (1984) comparing different routes of uptake in guppies have shown that dietary 
uptake o f PCBs was much more efficient than from water.
A few models have examined the extent o f PCB dietary transfer in relation to 
the food chain structure. A model by Connolly (1991), examining PCB concentrations 
in predators o f different feeding habits (flounder and lobster), have shown that even 
though dietary uptake of PCBs by both species exceeded gill uptake, greater accumula­
tion occurred for those predators more closely associated with the benthic elements of 
the food chain. The length of the food chain, as much as its structure, may influence 
the extent o f PCBs bioaccumulation (Rasmussen et al., 1990; Evans et al., 1991; 
Bentzen et al., 1996). Concentrations in tissues o f trout in the Great Lakes were shown 
to increase with the length of the food chain (Rasmussen et al., 1990; Bentzen et al., 
1996), with a contribution of 3.5-fold biomagnification factor for each trophic 
component (Rasmussen et al., 1990). Likewise, Evans et al. (1991) have showed an 
increase from 1.3 to 12.9-fold for PCBs in a Lake Michigan food web, for successive 
trophic levels.
The controversy involving the relative importance o f the various routes of 
exposures appears to be based on methodological differences. Comparisons o f lipo­
philic chemical bioaccumulation in different systems should take into account as many 
variables as possible, including chemical properties, conditions of exposure, food 
chain structure, metabolism, excretion and the refinement o f modeling. Utilization of 
solvent carriers, as well as concentrations beyond solubility limits have been cited as 
factors that could result in overestimation of chemical uptake from the water (Harding
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
et al., 1981; Lederman and Rhee, 1982). Likewise, it has been stated that omission of 
parameters such as gill area and fish feeding rate when modeling bioaccumulation 
could otherwise result in the overestimation o f  dietary intake (Barber et al., 1991).
BIOCHEMICAL EFFECTS 
Studies in mammals have shown that the biochemical, as well as the toxic 
effects o f  polychlorinated biphenyls (PCBs), are determined by the position of their 
halogen substitutions (Safe et al., 1985; McFarland and Clarke, 1989). Those PCBs 
containing either non- or mono-ortho chlorines can assume a coplanar configuration, 
and bind to the cytosolic aryl hydrocarbon (Ah) receptor. Upon ligand binding, the Ah 
receptor dissociates from a heat shock protein (hsp90), and associates with the aryl 
hydrocarbon receptor nuclear translocator (ARNT) (Swanson and Bradfield, 1993; 
Schmidt and Bradfield, 1996). The Ah receptor-ARNT complex, in turn, binds to 
specific sequences in promoter regions of the target genes, effecting CYP1A induction 
and other toxic effects. The molecular mechanism of CYP1A induction in fish has not 
been fully clarified, but the Ah receptor has been identified in several fish species 
(Hahn et al., 1992; Hahn et al., 1997; Roy and Wirgin, 1997), and recent studies have 
also identified a functional ARNT protein in killifish (Powell et al., 1999).
Induction of hepatic CYP1A parameters by controlled laboratory exposures to 
PCB mixtures has been demonstrated in several fish species, including rainbow trout 
(Elcombe and Lech, 1979; Melancon and Lech, 1983), sheepshead (James and Little, 
1981), and carp (Melancon et al., 1981; Melancon and Lech, 1983). These studies have 
suggested that individual coplanar PCB congeners present in the PCB mixtures
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account for the CYPlA-related induction effects o f the commercial products. In 
sheepshead, induction o f metabolizing enzymes by 3,3’,4,4\5,5’-hexachlorobiphenyl 
was similar to observed with Aroclor 1254 (James and Little, 1981). Similar results 
were seen in rainbow trout and carp, where 3,4,3\ 4 ’-tetrachlorobiphenyl induced 
monooxygenase activities comparable to Aroclor 1254 exposures (Melancon and 
Lech, 1983). Studies with individual isomers have additionally demonstrated a lack of 
effect of non-coplanar PCBs on CYPlA-related parameters (Melancon et al., 1981; 
Gooch et al., 1989). Gooch et al. (1989) showed that parenteral CYPlA-related 
parameters were induced in scup liver following administration o f a coplanar PCB, 
while three other ortho-chlorinated PCBs failed to do so. Likewise, no CYPlA-related 
effects were seen in carp treated with the non-coplanar PCB 2,2\4 ,4’-TCB (Melancon 
et al., 1981).
The coplanar 3,4,3’,4’-tetrachlorobiphenyl (TCB) has been widely used as a 
model Ah receptor ligand in fish, and has been shown to induce hepatic CYP1A in 
rainbow trout (Melancon and Lech, 1983; Otto et al., 1997), dab (Sleiderink and Boon, 
1996), winter flounder (Monosson and Stegeman, 1991), scup (Gooch et al., 1989; 
White et al., 1997a), fathead minnow (Lindstrom-Seppa et al., 1994), carp (Melancon 
and Lech, 1983), and Atlantic tomcod (Wirgin et al., 1992). The hepatic induction of 
CYP1A by TCB in fish appears to be dose-dependent, with increases in CYP1A 
catalytic activity, as well as CYP1A transcription and protein expression both in vitro 
and in vivo (Gooch et al., 1989; Hahn et al., 1993; Lindstrom-Seppa et al., 1994). 
Above a maximum induction level, a decline in CYP1A catalytic activities is
17
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observed, apparently caused by increased TCB tissue levels that result in inhibition of 
CYP1A catalytic activity (Monosson and Stegeman, 1991; Hahn et al., 1993; White et 
al., 1997a).
METABOLISM
Early studies have suggested that fish were limited in their ability to metabolize 
polychlorinated biphenyls (PCBs) (Hutzinger et al., 1972). In these studies, brook trout 
orally dosed with three PCB congeners (4-chlorobiphenyl, 4,4’-dichlorobiphenyl, 
2 ,2\5,5’-tetrachlorobiphenyl, and 2,2’,4,4’,5,5’-hexachlorobiphenyl) failed to demon­
strate hydroxylated metabolites in the water, within four days of exposure. Subsequent 
investigations have demonstrated formation of polar metabolites o f 2,2’,5-trichloro- 
biphenyl, 2,2’,5,5’-tetrachlorobiphenyl, and 2,2’,4,5,5’-pentachlorobiphenyl in whole 
body preparations of the green sunfish (Sanborn et al., 1975), and conjugated metabo­
lites o f 2,2’,5,5’-tetrachlorobiphenyl in bile from rainbow trout (Melancon and Lech, 
1976).
Depletion of PCB congeners from tissues, and the relative abundance o f PCB 
congeners in different trophic levels o f the aquatic food chain have also been used to 
investigate the metabolism of PCBs in aquatic species. Niimi and Oliver (1983) exam­
ined the temporal elimination of 31 different PCB congeners from muscle and whole 
body of rainbow trout, following a single oral dose. It was noted that elimination was 
enhanced for those PCB congeners o f lower chlorine content, no ortho-chlorine sub­
stitutions, and vicinal unsubstituted carbons. Similar selectivity was observed in 
studies with winter flounder from New Bedford Harbor for those PCB congeners
18
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containing adjacent unsubstituted meta-para carbons (Elskus et al., 1994). 
Comparisons of relative abundance in the food chain have shown that in general, 
unsubstituted vicinal ortho-meta positions with no more than one ortho substitution, 
and unsubstituted vicinal meta-para positions appear to favor metabolism in lower 
aquatic organisms (Boon et al., 1992; Walker, 1992).
The involvement o f the different P450 isoforms in the metabolism of PCBs has 
been deduced from comparison o f PCB congener distributions in the aquatic fauna to 
those patterns seen in mammalian species (Brown, 1992). Patterns in aquatic animals 
were classified as CYPlA-like and CYP2B-like, according to resemblance to altera­
tions effected by those P4S0 isozymes in mammals. O f the fish species examined, 
CYPlA-like alterations were frequently observed, while CYP2B-like alterations were 
seen only in a few species. Recent studies with scup, examining the hepatic 
metabolism of 3,4,3’,4’-tetrachlorobiphenyl (TCB), provide the first measured rates o f 
TCB metabolism in fish, in addition to evidence that CYP1A may be involved (White 
et al., 1997b). These authors demonstrated that the rates o f metabolism of TCB in scup 
are very low in comparison to previous reports in mammalian species.
INTESTINAL XENOBIOTIC ABSORPTION 
CHEMICAL UPTAKE OF LIPID-SOLUBLE COMPOUNDS 
Transfer o f lipophilic compounds across the intestinal membrane may occur 
through passive or carrier-mediated diffusion, active transport and pinocytosis. O f 
these transcellular processes, passive diffusion is the mechanism most likely to be 
involved in the absorption o f lipophilic xenobiotics in the intestine (Thomson and
19
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Dietschy, 1981; Kuksis, 1984). The mechanism by which lipophilic xenobiotics 
traverse the intestine in fish is not completely understood, but evidence indicates that it 
is closely associated with digestion and absorption o f dietary fat. Facilitated absorption 
of lipophilic compounds in the presence of triglycerides have been demonstrated to 
occur in fish (Van Veld, 1990), an association previously described for lipid-soluble 
drugs and vitamins in mammals (Bloedow and Hayton, 1976; Kuksis, 1984; 
Yoshitomi et al., 1987). Triglycerides are hydrolyzed in the intestine by pancreatic 
lipases, and the released fatty acids are solubilized by bile salts forming micelles. 
Highly lipophilic compounds appear to be incorporated into lipid micelles in order to 
reach the absorptive epithelium (Vetter et al., 1985). In vitro studies by Laher and 
Barrowman (1983), utilizing the PCB mixture Aroclor 1242, have shown that the PCB 
carrying capacity o f micelles is favored by long chain polyunsaturated fatty acids, 
compared to shorter chains or monounsaturated components. These latter studies 
suggest that stereochemical factors might be influential in the association o f chemicals 
and micelles, so that micelle carrying capacity will be dependent both on the lipid 
composition of the micelle, and the compound to be solubilized.
The movement of lipophilic compounds across the intestinal membrane in fish 
species is thought to occur according to either one of two proposed models. The model 
proposed by Gobas (Gobas et al., 1993) suggests that lipophilic xenobiotics diffuse 
across the intestinal mucosa following a fugacity gradient. The leaving tendency 
(fugacity) of xenobiotics in the lumen is believed to increase following food volume 
reduction by digestive processes, and by the reduction o f  lipid content in the lumen. A
20
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second model proposes that lipophilic xenobiotics and dietary lipids are codigested, 
codispersed, and coassimilated across the intestinal epithelium (Vetter et al., 1985). In 
the latter, following absorption, xenobiotics are incorporated into fat vacuoles which 
are formed by the products o f lipid digestion that are resynthesized to triglycerides 
within the smooth endoplasmic reticulum.
MODULATORS OF BIOAVAILABILITY 
Intestinal Biotransformation 
Once in the enterocyte, xenobiotics may be excreted back to the intestinal 
lumen by counter-transport processes, may enter the systemic circulation as parent 
compounds, or undergo metabolism prior to absorption or elimination. Biotransforma­
tion usually, but not always, results in the formation of a more polar product, which 
often differs from parent compound in its ability to cross biological membranes. 
Studies have shown that the intestine o f fish is capable of most phase I and phase II 
biotransformation reactions, including cytochrome P450-dependent monooxygenase 
reactions and phase II conjugation (Lindstrom-Seppa et al., 1981; Van Veld et al., 
1988b; James et al., 1997). In comparison to liver, the major organ in xenobiotic 
biotransformation, the intestine expresses quantitatively lower levels o f biotrans­
formation enzymes, due to its relative lower mass. Intestinal metabolic activity in fish 
play a role in the transformation o f those chemicals present in low levels in the 
environment, but may be overwhelmed by very high levels of exposure (James and 
Kleinow, 1994). Intestinal enzymes, however, may reach levels comparable to liver 
following exposure to environmental inducers, when significant first-pass
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biotransformation of environmental contaminants may occur (Van Veld et al., 1987; 
Van Veld et al., 1988a; Van Veld et al., 1988b; Van Veld et al., 1991; James et al., 
1997; Kleinow et al., 1998).
Cytochrome P4501A (CYP1A) has received the most attention in relation to 
the intestinal oxidative metabolism o f xenobiotics in fish. CYP1A activity is 
commonly measured using assays such as ethoxyresorufin-O-deethylase (EROD), 
which represents primarily CYP1A activity (Stegeman and Hahn, 1994), and 
benzo(a)pyrene-3-hydroxylase (AHH), which is a measure o f P450 isozymes that 
include CYP1A. Low CYP1A concentrations and related activities have been 
demonstrated in the intestine of a variety o f uninduced fish species, including catfish, 
spot, toadfish, mummichog, and Atlantic tomcod (Van Veld et al., 1988a; Van Veld et 
al., 1988b; Van Veld et al., 1988b; Husoy et al., 1994; James et al., 1997; Van Veld et 
al.. 1997; Kleinow et al., 1998). Induction of intestinal CYPlA-related parameters 
have been shown to occur in various fish species, following exposure to a variety of 
Ah agonists (Van Veld et al., 1987; Van Veld et al., 1988a; Van Veld et al., 1988b; 
Van Veld et al., 1991; James et al., 1997; Kleinow et al., 1998). Van Veld et al. (1987) 
demonstrated that oral administration o f benzo(a)pyrene (BaP) (16 mg/kg diet) 
resulted in a 1.9-fold increase in total P450 content, as well a 8.5-fold increase in AHH 
activities in the intestine of spot. Similar results were seen with 10 mg/kg BaP or 3- 
mehtylcholanthrene (3-MC) exposures in spot, which effected respective 14- and 17- 
fold increases in intestinal AHH activities, 17- and 36-fold increases in EROD 
activities, and 2- and 1.9-fold increases in intestinal total P450 content (Van Veld et
22
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al.. 1988b). Similarly, studies with catfish have demonstrated increases in both 
intestinal EROD and AHH activities following administration o f P-naphthoflavone 
(BNF) (10 mg/ kg diet) (James et al., 1997; Kleinow et al., 1998). EROD activities in 
control catfish ranged from 1.9 to 3.6 pmol/min/mg protein, and increased to ~ 12 
pmol/ min/ mg protein following BNF exposure. AHH activities increased from ranges 
of 12.5 to 23.1 pmol/min/mg protein, in control animals, to ~ 70 pmol/min/mg protein 
in BNF-treated animals. These changes occurred without corresponding increases in 
total P450 content (James et al., 1997), which suggested that CYP1A possibly 
represents a small amount of total P450s in the catfish intestine. Overall, CYPlA- 
related activities appeared to be lower in catfish in comparison to other species 
examined. In addition, high doses o f dietary BNF at 100 mg/kg diet resulted in 
inhibition of EROD and AHH activity in catfish (James et al., 1997), while induction 
of EROD activity could be seen with much higher doses (250 mg BNF/kg diet) in 
mummichog (Van Veld et al., 1991). The inhibitory effect seen in catfish was 
attributed to the presence o f  residual BNF in the catfish intestine, which could have 
inhibited both EROD and AHH activities. These studies demonstrate that although 
dietary Ah agonists markedly affect the status o f  biotransformation enzymes in fish, 
the degree of induction may vary with species, inducer, and experimental differences.
Induction of intestinal biotransformation activities has been shown to modulate 
the systemic bioavailability o f xenobiotics. In catfish, administration o f dietary BNF at 
10 mg/kg diet for 15 days altered the degree o f metabolism o f a subsequent BaP dose, 
which affected the profile o f metabolites transferred to the intestinal circulation
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(Kleinow et al., 1998). Treatment with BNF resulted in an increase in the proportion of 
the potentially hazardous products BaP-7,8 and 9,10 dihydrodiols, as well as in a 
higher percentage o f unconjugated metabolites. Exposure to BNF, as well as higher 
BaP dose increased the systemic bioavailability of both parent BaP, as well as its 
metabolites. In studies with toadfish, exposure to dietary BaP at 10 mg/kg diet resulted 
in a higher percentage of BaP metabolites being transferred to the blood, in compari­
son to untreated animals (Van Veld et al., 1988a).
P-glycoprotein
P-glycoprotein (pgp) is a transmembrane energy-dependent efflux transporter 
initially discovered in tumor cells and associated with the multidrug resistance (MDR) 
phenotype (Juliano and Ling, 1976). Pgp is overexpressed following exposure to anti­
cancer drugs, and renders MDR resistance by preventing intracellular accumulation 
not only of the initial drug it was exposed to, but also to other structurally unrelated 
compounds. MDR genes have been shown to be highly conserved across species, 
being described in a wide variety o f  organisms, including rodents (Ng et al., 1989), 
nematoid worms (Broeks et al., 1995), and fish (Chan et al., 1992). The discovery of 
pgp expression in non-transformed tissues with secretory, excretory or barrier function 
has lead to the belief that the physiological function of pgp is associated with 
protection from natural toxins (Gottesman and Pastan, 1988; Ford and Hait, 1990). 
Normal tissues shown to express pgp include the intestine, liver, adrenal gland, brain 
capillaries, and kidney (Fojo et al., 1987; Thiebaut et al., 1987). In aquatic animals, a
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pgp-related multixenobiotic resistance (MXR) mechanism has been associated with 
defense against pollution (Kurelec, 1992).
Studies in mammals have suggested that intestinal pgp, in concert with first- 
pass biotransformation, may play a role in the variability seen in the systemic bioavail­
ability of orally administered drugs. Studies with human colonic adenocarcinoma cell 
line (Caco-2) demonstrated the vectorial transport of the pgp substrate vinblastine, as 
well as other compounds (P-blockers and quinidine) (Terao et al., 1996). Yumoto et al. 
(1999), utilizing both in vitro and in vivo techniques, demonstrated that the intestinal 
transport o f the pgp substrate Rhodamine 123 was inhibited by both CYP3A- and pgp- 
related compounds (e.g. midazolam, ketoconazole, verapamil, and quinidine). 
Corroboration of a pgp role in the intestinal bioavailability o f drugs was provided by 
kinetic studies in mice that showed that previous treatment with the pgp blocker SDZ 
PSC 833, a non-immunosuppressive cyclosporine analogue, decreased the systemic 
bioavailability of paclitaxel (van Asperen et al., 1997). Further evidence was provided 
by studies with MDR knockout mice, where animals which did not express functional 
pgp maintained higher systemic concentrations of paclitaxel following oral administra­
tion (Sparreboom et al., 1997). Immunohistochemistry studies have shown that pgp is 
prominent in the intestine of various fish species (Hemmer et al., 1995; Hemmer et al., 
1998; Kleinow et al., 2000), but a  modulatory role of pgp in the intestinal bioavailabil­
ity of chemicals in fish has not been established.
Mammalian MDR genes have been shown to be divided in two classes which 
code for different pgps, an inducible form involved in drug resistance, and a
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* constitutive apparently uninducible phosphatidylcholine translocator (Van Helvoort et
al., 1996). Partial cloning of two fish pgp genes in winter flounder have shown that the 
3’ ATP binding site and 3’ terminal exon are homologous to mammalian genes, but no 
specific relation to particular mammalian pgp isoforms could be established (Chan et 
al., 1992). Cursory studies in mammals have suggested that pgp and cytochrome 
P4501A (CYP1A) may work in coordination (Burt and Thorgeirsson, 1988; Gant et 
al., 1991; Bain et al., 1997). Failure o f model CYP1A inducers to elevate pgp expres­
sion in some experimental mammalian systems suggests that CYP1A and pgp are 
possibly coinduced, but are not coregulated. Studies in nonparenchymal rat liver 
epithelial cells have shown that exposure to 3-methylcholanthrene (3-MC) resulted in 
induction o f MDR mRNA but not CYP1A1 or CYP1A2 expression (Fardel et al., 
1996). Likewise, a lack of MDR induction was observed in primary hepatocyte 
cultures exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), with doses that 
induced maximum CYP1A induction (Gant et al., 1991). Induction o f both MDR and 
CYP1A was observed in the latter system following exposure to 3-MC, in contrast to 
the nonparenchymal epithelial cell system previously mentioned. These results in 
mammalian systems have lead to investigations of the interaction of C YP1A and pgp 
in fish. Studies with blenny have shown that elevated expression of both hepatic pgp 
and CYP1A were detected in fish exposed to a pulp mill effluent, as well as to crude 
oil under laboratory conditions (Bard et al., 1998). These studies exhibited a 
significant correlation between pgp and CYP1A expression in the liver o f fish exposed 
under laboratory conditions, indicating that both systems were responding against
26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
contaminant exposure. Similar indications were observed with carp exposed to water 
contaminated with Diesel-2 oil (Kurelec et al., 1995). In this study, hepatic CYPlA- 
related activity was not altered by exposure to oil alone, but rapidly increased 
following addition o f the pgp inhibitor verapamil. These results suggested that pgp 
inhibition resulted in increased uptake of Diesel-2 oil.
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CHAPTER 2: EFFECT OF MICELLE FATTY ACID 
COMPOSITION AND 3 ,43’,4’-TETRACHLOROBIPHENYL 
(TCB) EXPOSURE ON INTESTINAL [,4C1-TCB 
BIOAVAILABILITY AND BIOTRANSFORMATION IN 
CHANNEL CATFISH IN  S IT U  PREPARATIONS*
INTRODUCTION
Polychlorinated biphenyls (PCBs), ubiquitous contaminants in the aquatic 
environment (Fowler, 1990; Kalmaz and Kalmaz, 1979), exhibit high chemical 
stability, resistance to degradation, and high lipophilicity (Safe, 1984). The high 
lipophilicity of PCBs results in the association o f these chemicals with all components 
of the aquatic food chain (Connolly, 1991; James and Kleinow, 1994). PCBs undergo 
biomagnification through the food chain with higher trophic levels exhibiting greater 
accumulation than lower trophic levels (Biggs et al., 1980; Mayer et al., 1977; Oliver 
and Niimi, 1988; Rasmussen et al., 1990; Thomann and Connolly, 1984). The number 
of trophic steps in the food chain and composition of diet have been correlated to the 
magnitude of PCB transfer (Rasmussen et al., 1990). Mechanistic models suggest that 
90 to 99% of lipophilic contaminants in higher trophic level fish may result from food 
chain exposure (Thomann, 1989; Thomann et al., 1986).
A variety of physiochemical factors modulate the dietary bioavailability of 
PCBs. For PCBs within the low to moderate K<,w range an increasing partition 
coefficient has been shown to result in an increasing rate of uptake in fish (Chiou et 
al., 1977; Russell et al., 1995). In contrast, a compound K<,w above 6 appears to limit 
bioavailability (Gobas et al., 1988; Opperhuizen and Sijm, 1990). Likewise,
Reprinted with permission of Toxicoloeical Sciences. Oxford University Press.
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halogenation of PCBs has been shown to influence bioavailability with assimilation 
efficiencies o f  dietary PCBs inversely proportional to the chlorine content (Bruggeman 
et al., 1984; Tanabe et al., 1982). In general, compounds with lower molecular weights 
(Bruggeman et al., 1984; Niimi and Oliver, 1988) and small molecular volumes (Niimi 
and Oliver, 1988) tend to be more readily absorbed.
Fat in the diet as well as chemical solubility in triglycerides have been shown 
to facilitate absorption o f lipophilic contaminants (Kuksis, 1984). Micelles, formed by 
bile salt solubilization of dietary fat, are involved in the transport o f lipophilic 
xenobiotics to the intestinal wall (Gobas et al., 1993). Two models, both including 
lipid as an integral mechanistic component, have been proposed for the gastrointestinal 
uptake of lipophilic xenobiotics in fish. A fugacity (leaving tendency) based model 
proposed by Gobas et al. (1993) suggests that the driving force for chemical uptake is 
generated by digestive processes in the gastrointestinal lumen. Absorption o f dietary 
fat in the form o f fatty acids, through reduction o f the volume (increasing the relative 
concentration) and the changing character o f the luminal contents, increases the 
fugacity o f lipophilic xenobiotics from the intestinal lumen. This action facilitates the 
movement o f  lipophilic contaminants to the intestinal mucosa and ultimately the 
systemic circulation. A second model proposes that lipophilic xenobiotics are co­
assimilated from the gastrointestinal tract in direct association with dietary lipids 
(Vetter et al., 1985). These models suggest that dietary uptake of xenobiotics against 
an apparent concentration gradient, as with biomagnification, occurs in the consumer
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at either the level o f the intestine (model 1) or the tissues of deposition, with the latter 
occurring largely as a result o f  lipid incorporation or utilization (model 2).
PCB bioavailability along the food chain can be modulated by biotrans­
formation. In general, higher trophic levels exhibit PCB patterns enriched in highly 
chlorinated congeners (Boon et al., 1989; Muir et al., 1988). PCBs with unsubstituted 
adjacent para and meta positions, and congeners with unsubstituted adjacent ortho and 
meta positions and less than one orthochlorine are more readily biotransformed by 
oxidative systems such as cytochrome P450 as compared to PCBs with other 
characteristics (Boon et al., 1992; Walker, 1992). Metabolic activity limits the 
availability o f these lesser chlorinated compounds to higher trophic levels as a result of 
enhanced elimination by lower organisms. Recent in vitro and in situ studies also 
suggest that intestinal biotransformation o f dietary xenobiotics by the consuming fish 
can appreciably alter chemical form and systemic bioavailability (Kleinow et al., 1998; 
Van Veld, 1990). Fish intestinal CYP1A activity, inducible by a variety o f  Ah agonists 
(James et al., 1997; Kleinow et al., 1998; Van Veld et al., 1987; 1988a,b; 1991), may 
approach or even exceed concurrent hepatic levels following dietary exposure, when 
examined on a per mg protein basis (James et al., 1997; Van Veld et al., 1988b; 1991). 
The relative activity o f oxidative pathways in the intestine has been shown to influence 
the degree o f metabolism and composition o f absorbed xenobiotics. Similarly, phase II 
biotransformation pathways in the fish intestinal mucosa have been shown to be 
operative in the further modification of dietary xenobiotics, with dose and phase I 
activity as important determinants o f phase II contributions (Kleinow et al., 1998).
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3,4,3\4'-Tetrachlorobiphenyl (TCB), a coplanar PCB, is abundant in envi­
ronmental samples and animal tissues (McFarland and Clarke, 1989). The presence of 
TCB in higher organisms suggest that the compound may be subject to the foregoing 
dietary processes. While not much is known regarding the fate of TCBs in the fish 
gastrointestinal tract, TCB has been shown to be an inducer o f hepatic CYP1A in fish 
(Gooch et al., 1989; Lindstrom-Seppa et al., 1994; Monosson and Stegeman, 1991; 
Otto et al., 1997; Sleiderink and Boon, 1996; White et al., 1997a; Wirgin et al., 1992) 
and a substrate for fish hepatic CYP1A metabolism (White et al., 1997b). The 
induction o f fish hepatic CYP1A by TCB has been shown to occur in a dose- 
dependent fashion in the low dosage range, with increases in CYP1A catalytic activity, 
as well as CYP1A transcription and protein expression both in vitro and in vivo 
(Gooch et al., 1989; Hahn et al., 1993; Lindstrom-Seppa et al., 1994). In contrast, high 
TCB concentrations have been reported to elicit an inhibitory effect upon hepatic 
CYP1A catalytic activity (Hahn et al., 1993; Monosson and Stegeman, 1991; White et 
al., 1997a).
The following studies examined [UC]-TCB bioavailability from the catfish 
intestine with alteration of 3 factors: luminal lipid composition, existing TCB body 
burdens and intestinal biotransformation. The specific objectives o f this study were to 
examine the effect o f micelle fatty acid composition upon the solubility of TCB in 
micelles, the effect of micelle composition on TCB intestinal bioavailability in an in 
situ preparation, the effect o f a 10-day in vivo TCB exposure (0.5 or 5 mg TCB/kg 
diet) upon the bioavailability and biotransformation o f subsequent [I4C]-TCB
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exposures using an in situ intestinal preparation, the effect o f various TCB dosages 
upon CYP1A content and activity in the intestine, and the effect o f TCB dietary 
exposure upon intestinal morphology and integrity.
MATERIALS AND METHODS 
CHEMICALS
Radiolabeled (27.3 mCi/mM) [I4C]-3,4,3’,4’-tetrachlorobiphenyl (TCB) (98% 
isomer specific) was graciously supplied by H.B. Matthews, NIEHS, Research 
Triangle Park, NC. Nonradiolabelled TCB was purchased from ChemService Inc., 
West Chester, PA. The standards for the known hydroxylated TCB metabolites were 
generously donated by Dr. L. W. Robertson, University o f Kentucky, Lexington,KY. 
Tricane methane sulfonate (MS-222™) was obtained from Argent Chemical Company, 
Redmond, WA. TS-1™ tissue solubilizer was procured from Research Products 
International, Mount Prospect, IL. All other chemicals were obtained from Sigma 
Chemical Co., St. Louis, MO.
IN  VITRO  TCB SOLUBILITY IN MICELLES 
TCB solubility in micelles was examined in vitro in micelles o f differing fatty 
acid composition using a modification of previously described methods (Hollander 
and Rim, 1978). The various fatty acids selected were forms commonly found in 
tissues of catfish held at 20°C as determined by previous assays (Toth et al., 1993). 
Micelle mixtures (1 ml) were formulated at 40°C, by gentle mixing o f  0.9% saline, 10 
mM sodium taurocholate (bile salt for fatty acid emulsification), plus 10 mM o f either 
one or a combination o f 4 fatty acids (each exhibiting different chain lengths and
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degrees of saturation): (a) lauric acid (12:0); (b) myristic acid (14:0); (c) linoleic acid 
(18:2); and (d) a mixture o f equal concentrations (2.5 mM) o f  myristic acid (14:0), 
palmitic acid (16:0), stearic acid (18:0), and linoleic acid (18:2). Micelle production 
using these methods was confirmed by optical clarity over time and filtration.
TCB and [ l4C]-TCB (0.05 pCi) (20 pM total) in a toluene carrier (50 pi) was 
added on top o f 0.9% saline (1 ml) in a  conical glass tube. The solvent carrier was 
slowly evaporated under nitrogen until only a thin surface layer o f toluene with the 
TCB remained. This step removed excess toluene, which would otherwise precipitate 
the micelle mixture. Warm micelles (1 ml) as formulated above were slowly added 
below the surface o f the toluene, allowing the micelle mixture contact with the 
underside o f the toluene layer by temperature driven convection. TCB was allowed to 
partition into the micelles, as the remaining toluene was evaporated with nitrogen. 
Following complete evaporation o f the toluene layer, the solution was rigorously 
gassed with nitrogen to remove any remaining toluene and then shaken. Due to the 
nature of the micelle mixture (micelles in aqueous saline) the hydrophobic TCB not 
associated with the micelles was partitioned by hydrophobic interactions to the edge of 
the aqueous phase onto the glass. Relative [,4C]-TCB content in micelles o f each 
treatment was measured by liquid scintillation counting of timed samples using 3 
replicates (100 pi) from each micelle solution. Total TCB remaining in the micelle 
solution was expressed as a percentage o f  the total dose delivered.
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IN  SITU STUDIES 
Animals
Channel catfish (Ictalurus punctatus) o f either sex (1,379 ± 319 g) were 
obtained from the Louisiana State University Aquaculture Research Station at Baton 
Rouge, LA. Fish were kept on a 12-h light/dark photoperiod, in a flow through system 
supplied with dechlorinated tap water (pH 8.1 ± 0.2, temperature 19.4 ± 1.4°C, total 
hardness 27.1 ± 7.0 mg CaCCVL alkalinity 114.3 ± 12.9 mg/1). All animals were 
acclimated to experimental conditions at least 2 weeks prior to use. Animals were fed 
a custom made, purified, semisynthetic catfish diet (Dyets Inc., Bethlehem, PA) 
composed o f casein 32%, dextrin 29.8%, cellulose 19%, soybean oil 3%, Menhaden 
oil 3%, gelatin 8%, salt and vitamin mix 5%, and choline chloride 0.2%.
In Situ Intestinal Perfusions 
Catfish of both sexes were used for surgery and the in situ intestinal prepa­
ration. The first experiment examined the effect of micelle carrier composition on 
[14C]-TCB bioavailability in an in situ intestinal preparation of control animals. 
Following in situ intestinal preparation [l4C]-TCB (60 pM) was delivered into the 
intestinal lumen in a micelle carrier composed of either (1) 2.5 mM monolauroyl-rac- 
glycerol (a common mono-acyl-glycerol which is an incomplete lipolysis product), 10 
mM sodium taurocholate, and the mixture of 2.5 mM myristic acid, 2.5 mM palmitic 
acid, 2.5 mM stearic acid and 2.5 mM linoleic acid (n = 3), or (2) 2.5 mM 
monolauroyl-rac-glycerol, 10 mM sodium taurocholate, and 10 mM linoleic acid (n = 
5). In a second experiment designed to examine the effect o f TCB preexposure upon
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subsequent [>4C]-TCB intestinal bioavailability and metabolism, animals were 
exposed 10 days prior to the in situ preparation to control diets (n = 3) or diets 
containing nonradiolabeled TCB at 0.5 mg (n = 6), and 5 mg TCB/kg diet (n = 7). For 
all these treatments, [UC]-TCB (60 pM) was delivered in the in situ preparation, using 
the 10 mM linoleic acid micelle.
For the respective treatments o f both experiments, control animals were 
maintained on the semisynthetic diet coated with com oil (1 ml com oil/100 g of diet) 
while for the second experiment TCB was delivered in com oil applied as a coating on 
the semisynthetic diet (1 ml com oil/100 g of diet). Both dietary groups (control and 
dietary TCB exposure) were maintained on designated experimental diets at 0.5% of 
fish body weight/day for 10 days prior to the in situ intestinal preparation. Fish were 
fasted 24 hours prior to experimental manipulation.
In Situ [UC]-TCB Dose Preparation 
The micelle solution of defined composition used for intraluminal [14C]-TCB 
dosing of the intestinal preparation was formulated fresh daily as described in the in 
vitro section. Micelle compositions containing 60 pM of [I4C]-TCB (27.3 mCi/mmol) 
were formulated to a final volume of 3 ml.
Surgical Procedure and Dosing 
Surgical preparations were performed as previously described (Kleinow et al., 
1998). MS-222 buffered with NaHC03" was used for anesthesia at induction and 
maintenance dosages o f 106 and 86 mg/l, respectively. The intestine was exteriorized 
and a ventral loop of proximal intestine o f approximately 20 cm in length was selected
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for the preparation. Vessels perfusing the selected intestinal segment, including a 
branch of the coeliacomesenteric artery as the afferent (supply) vessel, the corre­
sponding efferent (drainage) vessel and potential collateral vessels were identified and 
isolated. The afferent vessel was cannulated using a PE-50 tubing filled with saline 
treated with citrate anticoagulant. Once in place, oxygenated blood containing citrate 
anticoagulant was pumped into the afferent cannula at a flow rate of 0.1 ml/min. PE- 
60 tubing was used to cannulate the efferent vessel and collateral vessels were tied off. 
Integrity of the perfusion was verified through measurement of efferent blood 
volumes. Upon completion o f the circuit the intestinal segment was transiently 
blanched with a small amount o f saline containing citrate anticoagulant via the afferent 
cannula, in order to demarcate the length of intestine perfused by the preparation. 
Ligatures were placed on the intestine at the borders o f the perfused region. Delivery 
of the micelle solution was performed by inserting the needle of the dosing syringe 
through the gut wall, securing the preplaced ligature over the needle and injecting the 
[l4C]-TCB micellar dose into a closed intestinal segment. The injected dose was then 
massaged to allow distribution throughout the segment, and the time was then 
initiated.
Sample Collection
Throughout the 60-min perfusion, the intestine was moistened with saline, the 
segment periodically massaged, and a composite blood sample collected. After the 60- 
min perfusion, the isolated, ligated intestinal segment was drained and the postinfusate 
collected. Aliquots of the postinfusate were taken for liquid scintillation counting and
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metabolite analysis. The intestinal segment was then cut open, washed copiously with 
ice cold saline and blotted dry. The mucosal layer was collected by scraping with a 
glass slide. Aliquots o f weighed mucosal tissue were taken for liquid scintillation 
counting, metabolite analysis, and preparations for P450 content and activity. Liver, 
kidney, and anesthetic water samples were collected and counted for radioactivity, to 
verify, by the lack o f counts, the integrity of the isolated preparation.
Blood, liver, kidney, mucosa and postinfusate samples (approximately 50 mg) 
were digested at 50°C in 0.5 ml o f TS-1 Tissue Solubilizer for 24 h, neutralized with 
18 pi o f glacial acetic acid and counted in 4.5 ml o f  scintillant (Ultima Gold, Packard, 
Downers Grove, IL). Water and preinfusate samples were not digested prior to 
counting. Corrections for counting efficiency (~ 95%) and background were utilized 
for all samples. Preinfusate, postinfusate, intestinal mucosa, and blood sampled for 
metabolite analysis were snap frozen with liquid nitrogen, wrapped in foil, and kept at 
-80°C until analysis. Mucosal samples for P450 related analysis were suspended in 
buffer consisting o f 0.25 M sucrose, 0.1 mM EDTA, 0.05 M Tris-HCl, pH 7.4, 0.1 
mM phenylmethyl sulfonyl fluoride (PMSF), and similarly frozen.
Enzyme Assays and P450 Content 
Mucosal samples were weighed and homogenized in 4 volumes o f buffer (0.25 
M sucrose, 5 mM EDTA, 0.05 M Tris-HCl, pH 7.4, 0.2 mM PMSF). Microsomal and 
cytosolic fractions were prepared using the procedure described by James and Little 
(1983). Total P450 content o f  microsomes was measured following the method of 
Estabrook et al. (1972), using a Shimadzu 265 spectrophotometer, as previously
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described (James et al., 1988). Monooxygenase activity was measured by a fluo­
rescence assay (AHH) of phenolic BaP metabolites (Nebert, 1978).
Western Blot Analysis 
Microsomal protein fractions (40 pg for intestine, 20 pg for liver), incubated in 
sample buffer as recommended by BioRad, were resolved in a mini gel format 
(BioRad) on 4% stacking gel with 8.5% resolving gels, as described by Laemmli 
(1970). Unstained and prestained molecular weight standards in the range o f 14,400 to 
97,000 (BioRad low molecular weight range) were resolved at the same time as the 
SDS-treated microsomes. Gentest Supersomes™ expressing rat CYP1A were used to 
develop a standard curve for quantitation o f the antibody response. Electrophoresis 
was carried out using a 25 mM Tris, 192 mM glycine, 0.10% SDS buffer at constant 
voltage of 200V. Western blot transfer o f protein to nitrocellulose was performed as 
described by Towbin et al. (1979). The transfer was carried out at 100V in a mini 
Transblot system (BioRad) using a 25 mM Tris, 192 mM glycine, 20% v/v methanol, 
pH 8.3 transfer buffer. The remaining gel was stained with Coomassie blue as an 
indication of transfer effectiveness.
Immunodetection was carried out using monoclonal antibodies to scup CYP1A 
(courtesy of Dr. J. J. Stegeman). Transblotted nitrocellulose was rinsed in a 20 mM 
Tris, 500 mM NaCl, pH 7.5 buffer and nonspecific binding sites blocked with 5% 
(w/v) dried milk in 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20 for 45 
min. The membrane was washed 4 times with 20 mM Tris, 500 mM NaCl, 0.05% 
Tween 20, pH 7.5 buffer. The primary antibody, diluted 1:10,000 in 5% (w/v) dried
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milk in 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20, was incubated 
with the nitrocellulose for 2 h. The unbound antibodies were washed away in 20 mM 
Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20 buffer and further incubated with a 
1:1,000 dilution of secondary antibody in blocking agent (rabbit anti-rat antibody 
conjugated to horseradish peroxidase) for 1 h. After washing with 20 mM Tris-HCl, 
pH 7.5, 500 mM NaCl, 0.05% Tween 20, the immunoreactive proteins were detected 
according to the Amersham Western Blotting kit for chemiluminescent detection and 
the protein bands were visualized by fluorography on Kodak X-OMAT AR films. 
Fluorograms were subsequently scanned and the protein bands were quantified by 
scan-analysis densitometry.
Metabolic Studies
Samples o f blood and postinfusate (1 ml) were extracted 3 times with (3 ml) 
heptane:ethanol, 19:1, and the three extracts pooled. Intestinal mucosa (0.3 to 0.6 g) 
was homogenized with 1 ml distilled water and extracted 3 times with (3 ml) 
heptane:ethanol, 19:1. For each sample, the pooled heptane:ethanol extracts were dried 
over anhydrous sodium sulfate, evaporated to dryness under nitrogen, and stored at - 
80°C until HPLC analysis. Before analysis, the residue was dissolved in 0.1 ml 78% 
methanol:water, the solution filtered (0.45 pm nylon filter) and 50 pi injected onto a 
pre-equilibrated C18 reverse phase HPLC column. Initial HPLC conditions at a flow 
rate of I ml/min were 78% methanol:22% water (held for 20 min) followed by a 
gradient to 100% methanol over 5 min (held for 10 min), and then returned over 5 min 
to 78% methanol. Analysis was accomplished using UV (262 nm) and radiochemical
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detection (INUS detector). Under these conditions, baseline separation o f  the known 
TCB metabolites was achieved. 2-OH-3,4,3’,4’-TCB eluted at 17.7 min, 4-OH- 
3,5,3\4'-TCB at 18.2 min, 5-OH-3,4,3’,4’-TCB at 18.7 min, 6-OH-3,4,3’,4’-TCB at 
19.6 min, and 3,4,3’,4’-TCB eluted at 22.6 min.
HISTOLOGICAL STUDIES 
To assess if  any morphological changes were induced in the intestine with TCB 
exposure, catfish (n = 18) were exposed to TCB following the same protocol as used 
for the in situ preparation. Animals were divided into 3 equal groups: control, 10-day 
dietary TCB exposure at 0.5 mg/kg diet, and 10-day dietary TCB exposure at 5 mg/kg 
diet. Following exposure, intestines were harvested, rinsed with ice cold 0.9% saline, 
and samples o f proximal and distal sections collected for histological preparation. 
Samples were fixed in 10% formalin for at least 24 h, and 4 pm sections stained with 
hematoxylin-eosin using conventional techniques.
STATISTICAL ANALYSIS 
Data analysis was completed using the statistical software SigmaStat (Win­
dows, version 1.0, Jandal Corporation, San Rafael, CA). One way ANOVA, Student’s 
/-test, or corresponding nonparametric tests were used to examine for significant 
differences at p  < 0.05. Multiple comparisons (Dunnet’s or Student-Newman-Keuls) 
were used when ANOVA demonstrated significant differences.
RESULTS
[l4C]-TCB carrying capacity of micelles varied, under in vitro conditions, with 
the fatty acid acyl side chain composition (Figure 2.1). As the fatty acid chain length
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Figure 2.1 - Effect o f  micelle fatty acid composition on mean [‘4C]-3,4,3\4’-tetra- 
chlorobiphenyl (TCB) solubility. Results shown as a percentage o f a 20 pM TCB dose 
incorporated into micelle carriers. Micelles were composed o f  0.9% saline, 10 mM 
sodium taurocholate, plus 10 mM fatty acids: (a) lauric acid (12:0), (b) myristic acid 
(14:0), (c) linoleic acid (18:2), and (d) an equal mixture o f myristic (14:0), palmitic 
(16:0), stearic (18:0), and linoleic (18:2) acids. Similar letters indicate significant 
differences ip < 0.05) (mean ± SD), (n = 3).
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increased from C12 to C18, there was a trend towards increased [l4C]-TCB solubility. 
[I4C]-TCB mean solubilities were significantly higher (2.6-fold) in linoleic acid (18:2) 
compared to lauric acid (12:0) micelles (ANOVA, Student Newman-Keuls: p  < 0.05), 
while myristic acid (14:0) micelles showed an intermediate solubility, not significantly 
different from the other 2 (ANOVA, Student Newman-Keuls: p  < 0.05). Mixed mi­
celles composed o f equal amounts o f myristic (14:0), palmitic (16:0), stearic (18:0), 
and linoleic (18:2) acids, exhibited a 3 to 7.6-fold lower [l4C]-TCB solubility when 
compared to micelles composed of the individual fatty acids.
The influence of [I4C]-TCB micelle solubilization upon systemic bioavailabil­
ity was examined in the in situ intestinal preparation using the micelle compositions 
exhibiting the greatest (linoleic acid) and least efficient [i4C]-TCB solubilization 
(mixture). With equivalent [14C]-TCB dose and preparation techniques, linoleic acid 
micelles facilitated a significantly greater systemic [14C]-TCB bioavailability than the 
mixed micelle solution (Figure 2.2). The mean systemic bioavailability with linoleic 
acid micelles (895.9 ± 217.9 pmol [14C]-TCB/ml blood) was approximately 2.2-fold 
higher than obtained with mixed micelle solution (401.9 ± 334.5 pmol [l4C]-TCB/ml 
blood) (/-test: p  < 0.05).
TCB at both the 0.5 and 5mg/kg dosages when administered in the diet for 10 
days significantly decreased subsequent [14C]-TCB systemic bioavailability to the 
blood of the in situ preparation (Figure 2.3) (ANOVA, Student Newman-Keuls: p  < 
0.05). When compared to the control animals (895.9 ± 217.9 pmol [u C]-TCB/ml of 
blood), TCB at 0.5 and 5 mg TCB/kg diets decreased blood concentrations of
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Figure 2.2 - Scatter graph showing the concentration of [l4C]-3,4,3 \ 4 ’-tetrachloro- 
biphenyl (TCB) in the blood o f in situ-isolated, perfused intestine of vehicle-treated 
(control) catfish with varying micelle carrier composition. Micelles were composed of 
0.9% saline, 2.5 mM monooleoyl-rac-glycerol, 10 mM sodium taurocholate, and 10 
mM of either an equal mixture of myristic, palmitic, stearic, and linoleic acids (n = 3), 
or linoleic acid alone (n = 5). [I4C)-TCB systemic bioavailability was significantly 
greater with the linoleic acid micelles (p < 0.05).
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Figure 2.3 - Scatter graph showing the concentration o f [l4C]-3,4,3’,4’-tetrachloro- 
biphenyl (TCB) in the blood, mucosa and postinfusate of in j/Vw-isolated, perfused 
intestines of individual vehicle-treated controls (n = 5) and 10-day TCB-preexposed 
catfish, dosed at either 0.5 mg TCB/kg diet (n = 6), or 5 mg TCB/kg diet (n = 7). 
Linoleic acid micelles were used for all treatments. Controls exhibited significantly 
greater [14C]-TCB concentrations in the blood compared to TCB pretreatments ip  < 
0.05).
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[I4C]- TCB 47% (475.7 ± 134.4 pmol/ml of blood) and 45% (495.6 ±  160.2 pmol/ml 
of blood), respectively. There was no significant interdose effect o f TCB dietary 
preexposure upon the intestinal systemic bioavailability o f [14C]-TCB.
[I4C]-TCB concentrations in intestinal mucosa, following the in situ perfusion, 
did not change with the increasing in vivo doses of the TCB preexposure (Figure 2.3). 
Mucosal [14C]-TCB levels o f 16.2 ± 5.6, 15.6 ± 7.9, and 13.9 ± 5.5 nmol/g mucosa 
were observed for control, 0.5 mg TCB and 5 mg TCB/kg-diet exposure groups, 
respectively. Mean postinfusate [14C]-TCB concentrations were 19.6 ± 6.3, 28.4 ±
17.0, and 30.7 ± 9.5 nmol [ l4C]-TCB/ml for the same treatments (Figure 2.3). The 
effects of TCB preexposure upon [14C]- TCB concentrations were not significant for 
either the mucosa or postinfusate (ANOVA: p  < 0.05).
For all treatments, the highest concentrations o f [14C]-TCB on a per-unit basis 
were found in the postinfusate, followed by the mucosa and then the blood. Postin­
fusate [l4C]-TCB concentrations were approximately 1.2, 1.8, and 2.2 times higher 
than mucosa concentrations in the controls, and animals preexposed to 0.5 and 5 mg 
TCB/kg diet, respectively. Mucosa concentrations as compared to blood were 18.1,
28.1, and 32.9 times greater for the same treatments. Consistent over all treatments, 
the largest contributor to the gradient difference from the intestinal lumen to the blood 
was that evident between the mucosa and the blood. The gradient differences observed 
between the lumen and blood were the lowest for controls (21.9x) rising nearly 3-fold 
for TCB-pretreated animals (59.7 to 61.9x). These results reflect the higher blood and
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lower postinfusate [14C]-TCB concentrations for the controls and the lower blood and 
higher postinfusate [14C]-TCB concentrations for TCB-pretreated animals.
Microsomal and cytosolic fractions produced by differential centrifugation of 
mucosa were examined for [l4C]-TCB radioactivity. As compared to the microsomes, 
lower amounts of radioactivity were associated with the cytosol on a per mg protein 
basis. The microsomal fractions exhibited similar amounts of [l4C]-TCB-derived 
radioactivity for all treatment groups (0.196 ± 0.039, 0.201 ± 0.60 and 0.236 ± 0.049 
nmol [l4C]-TCB/mg microsomal protein for control, 0.5 mg and 5 mg TCB/kg diet 
treatments, respectively). Control treatment cytosolic radioactivity values (65.6 ± 23.6 
pmol [I4C]-TCB/mg cytosolic protein) were significantly higher than those for either 
the 0.5 mg TCB/kg diet (32.4 ± 6.0 pmol [I4C]-TCB/mg cytosolic protein) or 5 mg 
TCB/kg diet (41.5 ± 14.6 pmol [l4C]-TCB/mg cytosolic protein) treatments (ANOVA: 
p < 0.05).
Total P450 content, CYP1A content, and aryl hydrocarbon hydroxylase (AHH) 
activities were measured, to assess the effect of TCB preexposure upon the metabolic 
capabilities of the catfish intestine. Mean P450 concentrations (between 0.07 and 0.09 
nmol/mg protein) were not significantly altered by TCB pretreatment (Figure 2.4) 
(ANOVA: p < 0.05). CYPIA cross-reactivity was not detected for either the controls 
or animals of the 0.5 mg TCB/kg diet treatments. CYPIA levels were variable for the 
5 mg TCB/kg diet treatment, with values ranging from 0.14 to 24.11 pmol/mg protein 
(Figure 2.5). Composite AHH activities (Figure 2.6) were 2.46 ± 1.16 , 2.43 ± 1.58 
and 11.35 ± 10.25 pmol/min/mg protein for the control, 0.5 and 5 mg TCB/kg diets,
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Figure 2.4 - Scatter graph showing the P450 content in intestinal microsomes from 
control catfish (n = 4) or animals exposed for 10 days to either 0.5 (n = 6) or 5 mg 
TCB/kg diet (n = 6).
CONTROL TCB 0.5 mg/ kg TCB 5 mg/kg
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Figure 2.5 - Western blot showing cross-reactivity of microsomes from individual fish 
treated with a 5 mg TCB/kg diet for 10 days against a monoclonal antibody to scup 
CYPIA. Lanes 1-7 are intestinal microsomes, 40 pg per lane, except lane 3 (20 pg). 
Lane 8 shows hepatic microsomes (20 pg) from the fish whose intestinal microsomes 
are shown in lane 7.
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CONTROL TCB 0.5 mg/ kg TCB 5 mg/kg
Figure 2.6 - Scatter graph of intestinal aryl hydrocarbon hydroxylase (AHH) activity in 
control catfish and catfish exposed for 10 days to TCB on either 0.5 or 5 mg TCB/kg 
diets.
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respectively. AHH activities o f the 5 mg/kg treatment were not significantly greater 
than controls or the 0.5 mg/kg diet treatments due to the high standard deviation o f the 
data (ANOVA: p  < 0.05). Four animals demonstrated large increases (~ 7-fold) in 
AHH activities, while 3 animals exhibited levels similar to the controls. AHH activity 
exhibited a strong correlation (r2 = 0.96) with CYP1A cross-reactivity (y = 1.143x + 
1.026) (Figure 2.7).
TCB was metabolized to a small degree (0.05 to 1.3%) in the intestinal mucosa 
of individual catfish in in situ preparations (Table 1). Analysis of tissue sample 
extracts by HPLC demonstrated 4 minor peaks which eluted before the parent. Three 
of these peaks were tentatively identified as 2-OH-3,4,3’,4’-TCB, 4-OH-3,5,3',4'-TCB 
and 5-OH-3,4,3’,4’-TCB by co-elution with standards. The fourth peak eluted much 
earlier (12.1 min) but remains unidentified.
TCB elicited few morphological effects in the intestinal tract of the 0.5 mg/kg 
diet dosage level whereas at 5 mg/kg, demonstrable changes were evident when 
compared to the controls. Among the changes consistently present were a narrowing or 
thinning of the submucosa with submucosal separation a common feature (Figure 2.8). 
Goblet cell numbers were also increased along the mucosal folds of TCB-treated 
catfish.
DISCUSSION
The solubilization of [14C]-TCB in micelles, when varying the chain length and 
degree of saturation o f the component fatty acids showed a significant 156% increase 
in [i4C]-TCB solubility for micelles containing linoleic acid (18:2) as compared to
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Figure 2.7 - Intestinal CYP1A content and AHH activity. This graph shows that 
CYP1A content, pmol/mg microsomal protein correlated in a linear fashion (r2 = 0.98, 
p  < 0.001) with AHH activity in intestinal microsomes of catfish exposed to a 5 mg 
TCB/kg diet and subsequently used for in situ studies of TCB bioavailability. The 
CYP1A content was determined by cross-reactivity with a scup CYP1A monoclonal 
antibody and quantitated relative to a rat CYP1A standard curve.
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Table 2.1 - Metabolites o f [14C]-3,4,3\4’-tetrachIorobiphenyl (TCB) found in blood, 
mucosa and postinfusate after in situ perfusion, for control and catfish preexposed to 
0.5 and 5 mg TCB/kg diet for 10 days.
% of total %  o f 2-OH- % o f 4-OH-
metabolites3 3,4,3',4'-TCBb 3,5,3’,4'-TCBb
Blood
Control 1.22 ±0.61 N.D. to 0.15 N.D. to 0.53
0.5 mg TCB/kg diet 1.01 ±0.62 N.D. to 0.43 N.D. to 0.52
5 mg TCB/kg diet 1.06 ±0.74 N.D. to 0.59 N.D.
Mucosa
Control 0.55 ±0.56 N.D. to 0.23 N.D. to 0.05
0.5 mg TCB/kg diet 0.57 ±0.32 N.D. to 0.41 N.D. to 0.02
5 mg TCB/kg diet 0.35 ±0.33 N.D. to 0.20 N.D. to 0.03
Postinfusate
Control 0.24 ±0.21 N.D. to 0.12 N.D.
0.5 mg TCB/kg diet 0.59 ±0.15 N.D. to 0.11 N.D. to 0.04
5 mg TCB/kg diet 0.51 ±0.08 N.D. to 0.24 N.D. to 0.11
Note: Peaks eluted before the parent compound were assumed to be metabolites. N.D., 
not detected, < 0.005% for mucosa and postinfusate, < 0.05% for blood.
a Total o f all extracted radioactivity that eluted before the parent compound.
b Peaks were tentatively identified by co-elution with standards.
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Figure 2.8 - The proximal intestine o f the channel catfish following a 10-day exposure 
to (A) vehicle controls (63x) or (B) 5 mg TCB/kg diet (llOx). Note thinning and 
separation o f submucosa (SM) and increased numbers o f goblet cells (G) in mucosal 
folds of TCB-treated catfish.
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lauric acid (12:0). An increase in solubilization o f  TCB was noted with increasing fatty 
acid chain length (linoleic acid 18:2 > myristic acid 14:0 > lauric acid 12:0). Studies 
with other compounds including vitamins (Takahashi and Underwood, 1974) and the 
PCB Aroclor 1242 (Laher and Barrowman, 1983) have demonstrated increased 
solubilization in micelles composed of long acyl side chain fatty acids. Laher and 
Barrowman (1983) demonstrated that Aroclor 1242 solubility in linoleic (18:2) and 
oleic acid (18:1) micelles was 146 and 85% higher, respectively, compared to octanoic 
acid (8:0). In this regard, TCB behaves in a manner similar to Aroclor 1242. The 
current studies suggest that TCB delivery to the intestinal wall and even, perhaps, 
retention in foodstuff lipid may be dependent upon the fatty acid composition. Stearic 
factors between the size of the micelle and the compound's molecular volume have 
been forwarded as a possible explanation for similar findings (Takahashi and 
Underwood, 1974). Mixed micelles in the current study appear to support a lower TCB 
carrying capacity than micelles composed o f  a single fatty acid type. The reasons for 
these findings are unknown; however, it appears likely that such a mixed composition 
influences the determinant stearic factors. Fatty acid composition may be an important 
consideration for fishes, as chain length and even saturation status may change 
seasonally with temperature and with diet.
In the proximal intestinal segment, as used in our in situ study, the systemic 
bioavailability of [14C]-TCB molar equivalents (Meq) (composite o f [14C]-TCB parent 
compound and metabolites) was significantly higher (~ 123%) when delivery was 
accomplished using linoleic acid micelles as when compared to micelles composed of
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a fatty acid mixture (myristic, palmitic, stearic, and linoleic acids). These results 
indicate that the differences in bioavailability of [UC]-TCB Meq in the catfish 
intestine may be related to the differences in micelle fatty acid composition and the 
TCB solubility in those micelles. Studies in the killifish indicate that the presence of 
fat in the diet facilitates absorption o f  lipophilic contaminants (Van Veld, 1990). 
Likewise, the solubility of PCB, DDT and BaP in triglyceride was directly correlated 
to intestinal absorption efficiency (Van Veld, 1990). The current studies take this 
concept one step further by suggesting that micelle composition may play a role in the 
modulation of lipophilic xenobiotic delivery to or through the intestinal wall. One 
mechanism which may contribute to the apparent differences in [I4C]-TCB Meq 
absorption with differences in micelle composition is the rate- and site-dependent 
intestinal absorption of fatty acids. Ockner et al. (1972), comparing absorption of 
linoleic acid micelles with palmitic acid micelles (19.2 mM fatty acid, 9.6 mM 
glyceryl-1-monooleate, 20 mM sodium taurocholate) in rats, demonstrated a greater 
uptake o f linoleic acid compared to palmitic acid (~ 37%) in the proximal intestine. In 
addition, these studies showed that linoleic acid was absorbed primarily by proximal 
intestine, and palmitic acid by distal intestine. Absorption o f triolein in killifish has 
been shown to occur primarily in the proximal intestine (Honkanen et al., 1985).
Blood [l4C]-TCB Meq concentrations were diminished, postinfusate levels 
were elevated and mucosal concentrations remained about the same for TCB-pre- 
treated animals as compared to the controls in the in situ preparations. These trends in 
tracer distribution suggest that after TCB preexposure at either dose, the subsequent
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[14C]-TCB Meq dosage was not as effectively absorbed. The systemic bioavailability 
of [14C]-TCB Meq in the 60-min in situ preparation of control catfish was 2.9 % of the 
total dose delivered in the linoleic acid micelles. Catfish preexposed to 0.5 and 5 mg 
TCB/kg diet exhibited, under identical in situ exposure conditions, [l4C]-TCB Meq 
bioavailabilities of 1.41 and 1.51%, respectively. In vivo PCB accumulation studies 
with catfish have demonstrated diminished uptake and rate of uptake following PCB 
preexposure in the diet (Hansen et al., 1976) or by the sediments (Dabrowska et al.,
1996). Similarly, models by Barber et al. (1991) and Clark et al. (1990) have described 
decreases in PCB uptake with increases in body burden. The in situ character of the 
current studies indicate that the decreases in [14C]-TCB uptake with TCB preexposure 
occur on a direct and temporally acute basis at the level of the intestine. Dietary 
pretreatment with unlabeled TCB effectively altered the [l4C]-TCB gradient 
established by the end o f  the in situ preparation. The composite postinfusate to blood 
[i4C]-TCB gradients were approximately 21:1 for controls and 59.5 to 61.5: 1 for 
TCB-pretreated animals. These changes with TCB pretreatment appeared to occur by a 
combined effect of lowering transport to the blood and retention of [l4C]-TCB in the 
postinfusate. These changes in systemic [l4C]-TCB uptake were evident in this 
isolated preparation, although mucosa [l4C]-TCB levels were not significantly 
different. For all treatments, the greatest [l4C]-TCB Meq gradients at the end of the 
perfusion were between the mucosa and the blood (18- to 33-fold) rather than between 
the postinfusate and the mucosa (1.2- to 2.2-fold). This observation probably reflects 
the relative lipid content o f these compartments.
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A variety of mechanisms could decrease the systemic bioavailability o f [l4C]- 
TCB Meq with TCB preexposure. Diffusion, one of those mechanisms, is often cited 
as a major means for the intestinal transfer of uncharged lipophilic xenobiotics in fish 
(McKim and Nichols, 1994). TCB preexposure may increase TCB tissue loads, which 
would decrease the diffusion gradient available to [I4C]-TCB from the intestinal lumen 
to the systemic circulation. Unfortunately, unlabeled TCB residues were not measured 
to directly confirm this hypothesis. While lower blood [l4C]-TCB concentrations with 
TCB pretreatment are consistent with this hypothesis, a couple of pieces of 
information do not wholly fit. The first is the lack of a clear dose-response relationship 
for [I4C]-TCB at the 0.5 and 5 mg TCB/kg dosages. Another confounding feature is 
the observation that mean mucosa [14C]-TCB concentrations were very similar for all 
treatments. It would appear logical that the gradient effects would be clearly seen with 
[14C]-TCB in this intermediate compartment. An interesting observation, which may 
relate to these discrepancies, is the significantly lower intestinal mucosa cytosolic 
[I4C]-TCB Meq values with TCB pretreatment. This effect may be due to unlabeled 
TCB occupying or modifying sites on proteins or lipids necessary for transport of 
[l4C]-TCB through the cytosol. In concert with the diffusional process, such a 
mechanism could impair [14C]-TCB Meq transport to the systemic circulation. A 
number of cytosolic moieties have been described as transporters for xenobiotics 
including glutathione S-transferase (Dixit et al., 1982), fatty acid binding proteins 
(Larsen et al., 1991), nuclear transfer proteins (Tierney et al., 1980) and lipoproteins 
(Vetter et al., 1985). The lack of a clear relationship of the total mucosal [l4C]-TCB
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counts to the gradient effects seen in other compartments is puzzling. Perhaps it is a 
reflection o f the phenomenon observed with the microsomal membranes whereby 
[I4C]-TCB Meq levels were held constant across treatments. Plasma membranes and 
other structures removed in the first differential centrifugation accounted for a large 
part of the total composite mucosal [ l4C]-TCB Meq and may have demonstrated a 
similar effect hiding any response to TCB exposure. The mechanism and the 
significance of such a response will require more investigation.
A number of studies have demonstrated that exposure of animals, including 
fish, to certain organochlorines alters the distribution o f a subsequent tracer dose of the 
same [!4C] organochlorine (Carpenter and Curtis, 1989; 1991; Gilroy et al., 1993; 
compounds dieldrin and chlordecone). A suggestion has been made that these effects, 
independent of changes in xenobiotic metabolism or total body lipid content, may be 
related to lipid composition. Qualitative changes in lipids have been correlated with 
organochlorine exposure, including changes in fatty acid profiles, alterations in 
triglycerides and phospholipids (Hansell and Ecobichon, 1974; Ishikawa et al., 1978), 
and modifications of plasma lipoproteins (Ishikawa et al., 1978). Plasma lipoprotein 
binding has been shown to facilitate organochlorine transport (including PCBs) in a 
variety o f animal species (including rat, trout, human) (Maliwal and Guthrie, 1982; 
Plack et al., 1979; Skalsky et al., 1979; Soine et al., 1982; Spindler-Vomachka and 
Vodicnik, 1984). Given the changes in disposition induced by other organochlorines, 
the possibility exists that TCB may elicit similar effects altering either the temporary 
storage or transport by the intestine itself or by the blood.
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Other processes that may be influential in xenobiotic bioavailability across the 
intestine may be inducible by TCB pretreatment. P-glycoprotein, an efflux transporter, 
has been identified in the catfish intestine (Kleinow et al., 1996). This transporter 
would reduce bioavailability by the transport of absorbed compound from the 
intestinal mucosa back into the intestinal lumen. Such an action could account for the 
observed findings. There currently exist conflicting results in the literature regarding 
the suitability- of PCBs for transport by P-glycoprotein in marine organisms (Galgani et 
al., 1996; Cornwall et al., 1995). Likewise, there are even contrasting responses 
relative to the inducibility of P-glycoprotein in the catfish intestine with TCB, 
dependent upon the assay methodology (Kleinow, unpublished data). Induction of 
binding proteins by Ah receptor agonists have also been shown to alter the disposition 
of organochlorines, such as TCDD, in the liver of mice (Poland et al., 1989). The 
significance of such mechanisms relative to these results can be only speculative at 
this time.
Since TCB has been shown to be an inducer of CYP1A and its associated 
activity in the fish liver, pretreatment with TCB may also alter intestinal [14C]-TCB 
Meq bioavailability by enhancing metabolism and the production o f polar metabolites. 
Metabolism data included herein indicates, however, that [ ,4C]-TCB was very 
recalcitrant to intestinal metabolism, with only small changes in the metabolite profile 
from TCB pretreatment. Lack of a correlation between changes in bioavailability and 
the metabolites formed further suggest that metabolism does not, or at best can only 
minimally, account for the observed differences.
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It is plausible that the decrease in the systemic bioavailability o f [l4C]-TCB 
may be related in part to a non-specific effect, caused by a toxic action of TCB 
pretreatment on the intestine. The 10-day dietary preexposure in the current study, 
which provided a TCB dose of approximately 25 pg TCB/kg body weight/day (5 mg 
TCB/kg diet at 0.5% body weight), resulted in a thinning o f the submucosa and an 
increase in mucus secreting Goblet cells. An increase in mucus production could 
contribute to a thickening of the unstirred layer along the intestinal wall, thus 
increasing the diffusion distance and decreasing the rate of uptake. Similar effects are 
known to modulate nutritive and xenobiotic absorption in mammals (Kellaway and 
Marriot, 1975; Smithson et al., 1981). Considerable variation in the gastrointestinal 
toxicity of PCBs have been reported for fishes. A PCB mixture containing 2- 
chlorobiphenyl, 2,2’-dichlorobiphenyl, 2,5,2’-trichlorobiphenyl and 2,5,2’, 5’- 
tetrachlorobiphenyl (125 pg PCB/kg body wt/day for 28 days) elicited an increase in 
mucosal exfoliation, cytoplasmic inclusions in the columnar cells and a reduction or 
absence of the mucosa brush border in some areas of the chinook salmon intestine 
(Hawkes et al., 1980). In contrast, channel catfish fed 600 pg PCB (Aroclor 1242)/kg 
body weight/day for more than a 100-day period exhibited no histopathological 
changes in the gastrointestinal tract (Hansen et al., 1976). It is unclear whether 
differences between studies are related to the PCBs used, the dosage, or other factors.
Intestinal AHH activity and CYP1A content were not affected by the 0.5 mg 
TCB/kg-diet pretreatment and showed induction, but great variability, with the 5 mg 
TCB/kg diet. The consistency of AHH activities at near-control values for the 0.5 mg
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TCB/kg-diet dose, and the lack of detectable CYP1 A, suggests that this dosage may be 
insufficient to induce intestinal AHH activity when fed at approximately 0.5% of body 
weight. Conversely, detectable CYP1A content and AHH activities ranges from 
control levels to more than 12-fold higher with the 5 mg TCB/kg diet dosage indicate 
that TCB is capable o f intestinal induction. Previous studies have demonstrated dose- 
dependent induction and inhibition of fish hepatic CYP1A catalytic activities by TCB 
with induction at low and high doses while inhibition occurs only at high dosages 
(Gooch et al., 1989; Lindstrom-Seppa et al., 1994; White et al., 1997a). The 
differential response seen in the catfish intestine is most likely differential induction 
resulting from factors associated with compound ingestion and bioavailability. Direct 
correlation of AHH activity with CYP1A content for individual animals suggest that 
the variability was not related to TCB inhibitory effects. Studies determining TCB 
bioavailability and local TCB concentrations in the intestine following dietary 
exposure will be required to elucidate the dosimetry and extent of induction and in 
turn the inhibitory effects o f TCB in the catfish intestine.
[I4C]-TCB, as administered in the in situ  intestinal preparation, was poorly 
metabolized during the 60-min perfusion. In controls, approximately 0.55% of [14C]- 
TCB Meq in the mucosa were metabolites while 0.57 and 0.35% o f the [I4C]-TCB 
Meq in the 0.5 and 5 mg TCB/kg diet treatments were metabolites. Intestinal [14C]- 
TCB metabolism was highly variable between animals, but in all cases was quan­
titatively a minor event. O f the small amount o f metabolites formed in the mucosa, the 
predominate from tentatively identified by co-elution with standards for both the
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controls and TCB-pretreated animals was 2-OH-3,4,3’,4’-TCB. 4-OH-3,5,3’,4’-TCB 
was found as a metabolite of [,4C]-TCB in only 3 of 10 TCB-pretreated catfish. The 
catfish intestine exhibited no changes in metabolite profile with dose. In contrast, TCB 
metabolites in scup (Stenotomus chrysops) bile demonstrated a differing profile with 
the magnitude o f the TCB dosage (White et al., 1997b). At a dosage o f 0.1 mg 
TCB/kg, 5-OH-3,4,3’,4’-TCB was the major metabolite (85%) followed by 4-OH- 
3,5,3’,4’-TCB (13%) and 2-OH-3,4,3’,4’-TCB and 6-OH-3,4,3’,4’-TCB (1% each). 
Bile of scup treated with 5 mg TCB/kg contained higher amounts of 4-OH-3,5,3’,4’- 
TCB, comparable to the amounts o f 5-OH-3,4,3\4’-TCB. White et al. (1997b), in their 
study with scup, hypothesized that high doses of TCB inhibited CYP1A allowing other 
CYP to produce greater amounts o f 4-OH-3,5,3’,4’-TCB through a rearrangement of a 
4,5-epoxide. Results of the current study suggest that CYP1A is a minor constituent of 
the total CYP in the catfish intestine. The foregoing line of reasoning would suggest 
that the intestine should proportionally produce more 4-OH-3,5,3’,4’-TCB rather than 
less. Further studies are needed to determine if the differences with the current study 
are organ, species or experimentally related.
These studies have demonstrated (1) that fatty acid composition has an 
appreciable effect on the micelle-carrying capacity and subsequent intestinal bioavail­
ability of [I4C]-TCB, (2) that a previous TCB exposure may reduce the subsequent 
bioavailability o f [14C]-TCB to the systemic circulation (this effect is not related to 
first pass intestinal metabolism), and (3) that first pass intestinal metabolism o f TCB is
73
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a minor event with the production of small amounts o f metabolites including 2-OH-
3,4,3',4’-TCB, 4-OH-3,5,3',4'-TCB, and 5-OH-3,4,3\4’-TCB.
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CHAPTER 3: INTESTINAL BIOAVAILABILITY AND 
BIOTRANSFORMATION OF 3,43%4’- 
TETRACHLOROBIPHENYL IN IN  S IT U  PREPARATIONS OF 
CHANNEL CATFISH FOLLOWING DIETARY TREATMENT 
WITH P-NAPHTHOFLAVONE
INTRODUCTION
Polychlorinated biphenyls (PCBs) are anthropogenic contaminants commonly 
found in aquatic ecosystems (Kalmaz and Kalmaz, 1979; Fowler, 1990). Aquatic 
animals can accumulate PCBs through exposure to contaminated diet, water or 
sediments. Lesser chlorinated PCB congeners frequently undergo oxidative metabo­
lism, and are eliminated by lower trophic level organisms. Highly chlorinated PCB 
congeners have been shown to accumulate, and biomagnify, in the various trophic 
levels of the aquatic food chain (Thomann and Connolly, 1984; Muir et al., 1988; 
Oliver and Niimi, 1988; Boon et al., 1989). It appears that the position of the halogen 
substitution in the different PCB congeners, as much as the degree of chlorination, 
determines the susceptibility o f PCBs to biotransformation. Structure-activity 
relationships for the oxidative cytochrome P450 (CYP) metabolism of PCBs in aquatic 
species have been deduced from relative comparisons o f congener contents in the 
various trophic levels (Boon et al., 1992; Walker, 1992). Studies in mammals have 
further related the chemical structure to the pathways of PCB metabolism. The 
presence of unsubstituted vicinal ortho-meta positions, with at least one meta or para 
substitution, have been shown to favor CYP1A metabolism in rat liver microsomes 
(Mills et al., 1985; Klasson Wehler et al., 1989). Ortho substitutions (non-coplanar) 
have been shown to promote CYP2B metabolism in similar tissues, especially in
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combination with unsubstituted vicinal meta-para positions (Kaminsky et al., 1981; 
Mills et al., 1985; Ishida et al., 1991).
Information regarding the metabolism o f individual PCB congeners in fish is 
sparse, and little is known regarding the contribution of the various tissues to the 
overall biotransformation o f PCBs. In vivo studies examining PCB metabolites in bile 
and tissues, or monitoring of tissue depletion of parent compound (Sanborn et al., 
1975; Melancon and Lech, 1976; Hinz and Matsumura, 1977; Niimi and Oliver, 1983; 
Boon et al., 1989; Brown, 1992; Elskus et al., 1994) provide little information 
regarding the organs involved, as well as rates and pathways o f  PCB metabolism. 
Recent studies with the coplanar PCB, 3,4,3’,4’-tetrachlorobiphenyl (TCB), an 
abundant contaminant in the environment (McFarland and Clarke, 1989), suggest that 
TCB is metabolized to a substantial extent in the liver of scup (White et al., 1997). 
Hepatic biotransformation in this fish species was shown to vary with the TCB dose 
administered, and the TCB metabolite profile appears to be influenced by CYP1A 
content and activity, indicating that TCB may be a substrate for CYP1A (White et al., 
1997).
Intestinal CYP1A biotransformation has been demonstrated in a number of fish 
species following exposure to dietary Ah receptor agonists (Van Veld et al., 1988b; 
James et al., 1997). Studies with [3H]-benzo(a)pyrene (BaP) suggest that induction of 
intestinal biotransformation by such agonists may influence the profile of BaP derived 
compounds absorbed into the systemic circulation by the fish (Van Veld et al., 1988a; 
Kleinow et al., 1998). In contrast, recent in situ studies examining [,4C]-TCB
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metabolism in the intestine of catfish have demonstrated little correlation between the 
extent of metabolism or the profile o f metabolites produced with induction o f CYP1A 
related activity (Doi et al., 2000). Likewise, there was little correlation of these factors 
with apparent changes in [,4C]-TCB bioavailability following TCB in vivo 
preexposure and induction with TCB (Doi et al., 2000). Non-specific toxicity and 
changes in diffusion gradients (as a result o f increased TCB burden) were suggested as 
possible operative features in altered bioavailability (Kleinow et al., 1998; Doi et al., 
2000).
The objectives of the present study were to examine the effects o f  in vivo 
dietary BNF exposure, on the intestinal bioavailability and biotransformation of [l4C]- 
TCB, to further examine these issues. BNF was chosen for its known dose-dependent 
CYP1A inducing abilities in a number o f fish species (Melancon et al., 1981; 
Andersson et al., 1985; Tate, 1988; Kloepper-Sams and Stegeman, 1989; James et al.,
1997), as well as its independence relative to TCB diffusion gradients. Histological 
studies were performed to examine the correlation between BNF related structural 
changes and modulation o f [I4C]-TCB bioavailability. For this purpose, dietary BNF 
was administered to catfish, and its effects on intestinal oxidative metabolism and 
organ morphology were examined in context with changes in [l4C]-TCB systemic 
bioavailability and metabolite profile. Control catfish and animals exposed in vivo for 
10 days to different doses o f dietary BNF (10 and 50 mg BNF/kg diet) were used in an 
in situ perfused intestinal preparation.
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MATERIALS AND METHODS 
CHEMICALS
Radiolabelled (27.3 mCi/mM) [14C]-3,4,3’,4’-tetrachlorobiphenyl (TCB) was 
generously provided by H. B. Matthews, NIEHS, Research Triangle Park, NC. 
Standards for TCB hydroxylated metabolites (2-OH-3,4,3’,4’-TCB, 4-OH-3,5,3’,4’- 
TCB, 5-OH-3,4,3’,4’-TCB, and 6-OH-3,4,3’,4’-TCB) were a courtesy o f Dr. L. W. 
Robertson, University of Kentucky, Lexington, KY. Tricaine methane sulfonate (MS- 
222™) was purchased from Argent Chemical Company, Redmond, WA. TS-2™ tissue 
solubilizer was supplied by Research Products International, Mount Prospect, IL. All 
other chemicals were obtained from Sigma Chemical Co., St. Louis, MO.
ANIMALS
Male and female channel catfish (Ictalurus punctatus) were obtained from the 
Louisiana State University Aquaculture Research Station, Baton Rouge, LA. Fish 
(1,308 ± 345 g) were acclimatized to experimental conditions for at least 2 weeks prior 
to dosing. All animals were maintained on a 12 h light/dark photoperiod, in a 
dechlorinated tap water flow through system (pH 8.1 ± 0.2, temperature 19.7 ± 1.3°C, 
total hardness 24.4 ± 4.3 mg CaC03 /l, alkalinity 111.7 ± 10.9 mg/1). A custom made 
semi-synthetic diet (Dyets Inc., Bethlehem, PA), composed o f casein 32%, dextrin 
29.8%, cellulose 19%, soybean oil 3%, Menhaden oil 3%, gelatin 8%, salt and vitamin 
mix 5%, and choline chloride 0.2%, was fed to animals throughout the acclimation 
period, and was used as the base diet in experimental treatments.
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IN  S IT U  PROTOCOL 
Experimental Diets
Three dietary treatments were administered to separate groups o f catfish, in 
order to examine the effects of BNF pretreatment upon the intestinal bioavailability 
and biotransformation o f subsequent [l4C]-TCB exposures. Experimental diets were 
prepared by coating semi-synthetic diet with pure com oil (1 ml com oil/100 g diet) or 
com oil containing BNF (1 or 5 mg BNF/1 ml com oil/100 g diet). Control animals 
received semi-synthetic diet with com oil vehicle (n = 5), while BNF-treated groups 
received either the 10 mg BNF/kg diet (n = 3), or 50 mg BNF/kg diet (n = 4). Diets 
were fed ad libitum , at 0.5% body weight, for 10 days prior to in situ intestinal 
preparations. All animals were fasted 24 h prior to surgery.
[I4C]-TCB Dose Preparation 
A micelle solution (final volume o f 3 ml) containing radiollabeled TCB was 
prepared according to previously described methods (Doi et al., 2000), and used for 
dose delivery into the in situ isolated perfused intestine. The constituents of the 
micelles were selected to allow for TCB solubility, as determined in previous studies 
(Doi et al., 2000). Micelles were formulated with 2.5 mM of monolauroyl-rac- 
glycerol, a product o f incomplete lipolysis, 10 mM of the bile salt sodium taurocholate 
(used for lipid emulsification), and 10 mM of linoleic acid, a common constituent of 
catfish tissues (Toth et al., 1993). All constituents were added to 1.5 ml of 0.9% saline 
and gently stirred at 40°C. 60 pM of [,4C]-TCB (27.3 mCi/mM) in toluene carrier was 
loaded on top o f 1.5 ml o f  0.9% saline, and slowly evaporated under nitrogen until a
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surface film of TCB in toluene remained. A fresh micelle mixture (1.5 ml) was slowly 
added below the toluene surface film, and the remaining toluene evaporated with 
nitrogen, facilitating the transfer o f [l4C]-TCB to the micelle solution. The micelles 
were then carefully gassed with nitrogen to ensure that no toluene remained, and 
gently vortexed. Liquid scintillation counting (LSC) o f [,4C] content (2 pi) was 
utilized to ensure proper dose formulation.
Surgical Procedure and Dose Administration 
The surgical preparation of the intestinal segment and compound dosing were 
performed as described in detail in Kleinow et al. (1998). Animals were anesthetized 
(buffered MS-222, 106 and 86 mg/1 for induction and maintenance, respectively), and 
a ventral loop of proximal intestine (~ 20 cm) isolated for the in situ  preparation. After 
identification and isolation o f the appropriate vessels, the afferent vessel (a branch of 
the coeliacomesenteric artery) was cannulated (PE-50 tubing) and connected to a 
syringe filled with blood containing citrate anticoagulant. Syringe was then connected 
to a pump and blood perfused at a flow rate of 0.1 ml/min. The corresponding efferent 
vessel was then cannulated using a PE-60 tubing, and all collateral vessels ligated. The 
final demarcation of the intestinal segment perfused by the selected vasculature was 
performed by blanching the segment through the afferent vessel with saline with 
citrate anticoagulant, followed by placement of ligatures at the proximal and distal 
borders of the demarcated segment. The distal ligature was securely tied and the 
radiolabelled [l4C]-TCB dose (60 pM) in the 3 ml micelle solution delivered, by 
inserting the needle of the dosing syringe through the intestinal wall, into the isolated
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intestinal segment, under the preplaced proximal ligature. The ligature was then tied 
over the needle and the micellar dose injected into the isolated segment. The dose was 
massaged throughout the segment to ensure complete distribution. The vascular 
integrity o f the preparation was verified by monitoring the blood outflow, to ensure 
that all blood perfused was recovered.
Sample Collection
The isolated intestinal segment was perfused with blood for 60 min, following 
radiolabelled dose administration. A composite blood sample (one aliquot every 10 
min) was collected during the 1-h perfusion for LSC, and the remaining perfused 
blood used for metabolite analysis. At the end of the experimental period, the perfused 
segment was harvested, the intestinal contents (postinfusate) were drained and 
collected. The intestine was then cut open, profusely washed with cold saline, blotted 
dry, and the mucosa harvested by scraping with a glass slide. Postinfusate and mucosa 
samples were aliquoted for metabolite analysis and LSC. Samples for metabolite 
analysis (blood, postinfusate and mucosa) were snap frozen in liquid nitrogen and 
stored at -80°C until analysis. Mucosa samples aliquoted for P450 analysis were simi­
larly frozen and stored following suspension in storage buffer (0.25 M sucrose, 0.1 
mM EDTA, 0.05 M Tris-HCl, pH 7.4, 0.1 mM phenylmethylsulfonyl fluoride). 
Samples o f liver, kidney and anesthetic water were collected for LSC to verify the 
integrity o f the intestinal preparation (in properly isolated preparations, these samples 
display no radioactivity). Samples for LSC were digested at 50°C in 0.5 ml of TS-2 
tissue solubilizer for 24 h (with the exception of water), neutralized with 18 pi o f
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acetic acid and counted in 4.5 ml o f scintillant (Optima Gold, Packard, Downers 
Grove, IL). Corrections for counting efficiency (~ 95%) and background were 
performed for all samples.
Enzyme Assays and P450 Content 
Mucosa samples were weighed and homogenized in 4 volumes of buffer (0.25 
M sucrose, 5 mM EDTA, 0.05 M Tris-HCl, pH 7.4, 0.2 mM PMSF). Microsomes and 
cytosol were obtained by differential centrifugation as described in James and Little 
(1983). Total cytochrome P450 content was determined by spectrophotometry 
following the method o f  Estabrook et al. (1972), using a Shimadzu 265 spectropho­
tometer (James et al., 1988). Aryl hydrocarbon hydroxylase (AHH) activity was 
measured by the fluorescence assay of phenolic BaP metabolites (Nebert, 1978).
TCB Metabolite Analysis 
Samples o f blood, mucosa and postinfusate were extracted 3 times with 
heptane:ethanol, 19:1, dried over anhydrous sodium sulfate, and evaporated to dryness 
under nitrogen. Extracts were re-dissolved in 78% methanol:water, filtered through a 
0.45 pm nylon membrane and injected (50 pi) onto a C18 reverse-phase HPLC 
column. Gradient separation was performed using 78% methanol: 22% water (20 min), 
100 % methanol (5 min), and 78% methanol: 22% water (5 min), at a 1 ml/min flow 
rate. Detection used UV (262 nm) and radiochemical means (INUS detector). TCB 
metabolites were tentatively identified by co-elution with standards. Baseline 
separation of known TCB metabolites showed elution of 2-OH-3,4,3’,4’-TCB at 17.7
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
min, 4-OH-3,3’,4\5-TCB at 18.2 min, 5-OH-3,4,3’,4’-TCB at 18.7 min, 6-OH- 
3,4,3’,4’-TCB at 19.6 min, and parent 3,4,3’,4’-TCB at 22.6 min.
HISTOLOGICAL STUDIES 
In a separate study, catfish were assessed for morphological damage in the 
intestine following dietary BNF administration. Animals (n = 18) were divided into 3 
groups (n = 6) and received either control, or BNF treated diet at 10 and 50 mg 
BNF/kg diet. Following 10 days o f  dietary exposure, intestine was harvested, profusely 
rinsed with ice cold 0.9% saline, and samples of proximal and distal intestine 
collected. Samples were fixed in 10% formalin for at least 24 h, and 4 pm sections 
stained with hematoxylin-eosin following standard techniques.
STATISTICAL ANALYSIS 
The statistical software SigmaStat for Windows (Version 1.0, Jandal Corpora­
tion, San Rafael, CA) was used for data analysis. One way ANOVA and Student’s t- 
test were used to determine significant differences at p  < 0.05. Whenever ANOVA 
showed significant differences, multiple comparison tests were used (Student- 
Newman-Keuls).
RESULTS
[I4C]-TCB concentrations on a per-unit basis were highest in the postinfusate, 
and sequentially lower in the mucosa and the blood, for all treatments examined 
(Table 3.1). Postinfusate [UC]-TCB levels were approximately 1.3, 2.6, and 1.9-fold 
greater than mucosa concentrations for control catfish, and those animals preexposed 
to 10 mg and 50 mg BNF/kg diets, respectively. Mucosa concentrations were
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Table 3.1 - [uC]-3,4,3’,4’-Tetrachlorobiphenyl (TCB) concentration gradients 
between postinfusate and mucosa, and mucosa and blood interfaces following in situ 
perfusion, for control catfish and animals preexposed to 10 and 50 mg BNF/kg diet for 
10 days. Gradients were calculated as fold differences o f [UC]-TCB molar equivalents 
concentrations on a per-unit basis (postinfusate > mucosa > blood).
Postinfusate to 
mucosa
Mucosa to 
blood
Control 1.3 21.7
BNF 10 mg/kg 2.6 23.3
BNF 50 mg/kg 1.9 23.6
92
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
approximately 21.7, 23.3, and 23.6-fold higher than levels in blood for corresponding 
treatments. Across all treatments examined, the gradient differences were greatest 
between the blood and mucosa, as compared to differences seen between mucosa and 
postinfusate.
Blood [14C]-TCB molar equivalent (Meq) (combination of parent[l4C]-TCB 
and its metabolites) concentrations were 751.2 ± 262.6 pmol/ml, 645.5 ± 79.6 and 
612.4 ± 40.6 pmol/ml for control and animals exposed to 10 and 50 mg BNF/kg diet, 
respectively (Figure 3.1). The systemic uptake of [I4C]-TCB during the 60-min 
perfusion corresponded to 2.6, 2.1 and 1.9% of the total [ l4CJ dose administered, for 
the same respective treatments. Dietary treatment with BNF, at both doses, resulted in 
negligible effects upon [14C]-TCB systemic bioavailability in comparison to control 
animals, with no significant dose or interdose effects (ANOVA: p  < 0.05).
[14C]-TCB concentrations in intestinal mucosa, following in situ perfusion, 
remained constant with increasing doses of BNF preexposure. [I4C]-TCB mucosal 
concentrations of 16.3 ± 5.6, 15.0 ± 4.6, and 14.5 ±1.5 nmol/g tissue were detected for 
control, 10 mg and 50 mg BNF/kg diet, respectively (Figure 3.1). Postinfusate levels 
of [l4C]-TCB were less consistent across treatments, with values o f 21.4 ± 6.1, 39.0 ± 
16.2, and 28.0 ± 8.6 pmol/ml, for the same treatments (Figure 3.1). There were no 
significant dose or interdose effects of BNF pretreatment upon subsequent [I4C]-TCB 
concentrations in both mucosa and postinfusate of the in situ  preparation (ANOVA: p 
< 0.05).
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Figure 3.1 - Concentration o f [l4C]-3,4,3’,4’-tetrachlorobiphenyl in the blood, mucosa 
and postinfusate after 60-min incubation in in situ  isolated perfused intestine of (a) 
vehicle-treated catfish, and (b) following P-naphthoflavone (BNF) exposure to 10 mg 
and 50 mg BNF/kg diets for 10 days.
94
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The effect o f BNF pretreatment upon intestinal metabolism in the catfish was 
examined through determination of total P450 content, and AHH activity. Total P450 
concentrations were 0.08 ± 0.02, 0.07 ± 0.03, and 0.10 ± 0.02 nmol/mg for control, 
and BNF-treated animals at 10 and 50 mg BNF/kg diet, respectively (Figure 3.2). 
There were no significant changes in total P450 content following dietary treatment 
with BNF for either dose tested (ANOVA: p  < 0.05). As compared to controls (1.24 ± 
1.08 pmol/min/mg protein), there was a significant 9.2- and 12.5-fold increase in AHH 
activities, following exposure to 10 mg and 50 mg BNF/kg diet, respectively (Figure 
3.3). Interdose differences in AHH activity were not significant (ANOVA, Student- 
Newman-Keuls: p  < 0.05).
[14C]-TCB was biotransformed to a small degree in intestinal mucosa (0.54 to 
1.27%) during the 60-min in situ preparation (Table 3.2). [14C]-TCB metabolites were 
also detected in the postinfusate (0.24 to 0.37%) and in the blood (1.00 to 1.58%). 
Along with parent compound, four other peaks eluted in the analysis of sample 
extracts. Two of the peaks were tentatively identified as 2-OH-3,4,3’,4’-TCB and 4- 
OH-3,5,3',4'-TCB by co-elution with standards. Equivalent amounts of the two 
identified metabolites were found in blood, mucosa and postinfusate of nearly all 
treatments groups. The only exception were significantly lower blood levels of 4-OH- 
3,5,3',4-TCB in BNF-treated animals, in comparison to controls (ANOVA:p  < 0.05) 
(Table 3.2). There were no other significant effects of BNF treatment upon the extent 
and profile of metabolism o f  [I4C]-TCB in the catfish intestine (ANOVA: p  < 0.05).
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Figure 3.2 - Total cytochrome P450 content in intestinal mucosa of controls and 
catfish treated with P-naphthoflavone (BNF) at 10 and 50 mg BNF/kg diet for 10 days.
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Control BNF BNF 
10 mg/kg 50 mg/kg
Figure 3.3 - The effect o f  dietary treatment with {3-naphthoflavone (BNF) at 10 and 50 
mg BNF/kg diet for 10 days upon intestinal mucosa aryl hydrocarbon hydroxylase 
(AF1H) activity. * indicates statistical significance (p < 0.05).
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Table 3.2 - Metabolites o f [l4C]-3,4,3\4’-tetrachlorobiphenyl (TCB) detected in blood, 
mucosa and postinfusate following in situ perfusion, for control, and catfish exposed 
to 10 and 50 mg BNF/kg diet for 10 days prior to preparation.
% o f total % o f 2-OH- % o f 4-OH-
metabolites4 3,4,3\4’-TCBb 3,5,3’,4’-TCBb
Blood
Control 1.58 ±0.80 N.D. to 0.65 0.27 to 0.70
10 mg BNF/kg diet 1.00 ±0.25 0.22 to 0.37 N.D.
50 mg BNF/kg diet 1.00 ±0.13 N.D. to 0.25 N.D. to 0.18
Mucosa
Control 0.57 ± 0.36 N.D. to 0.21 N.D. to 0.20
10 mg BNF/kg diet 1.27 ±0.40 N.D. to 0.43 N.D. to 0.08
50 mg BNF/kg diet 0.54 ± 0.48 N.D. to 0.09 N.D. to 0.17
Postinfusate
Control 0.24 ± 0.08 N.D. N.D. to 0.05
10 mg BNF/kg diet 0.37 ± 0.09 N.D. to 0.10 N.D. to 0.03
50 mg BNF/kg diet 0.33 ± 0.05 N.D. to 0.12 N.D. to 0.03
Note: Peaks eluted before parent compound were presumed to be metabolites. N.D., 
not detected, < 0.005% for mucosa and postinfusate, < 0.05% for blood.
Total o f all extracted radioactivity that eluted before the parent compound.
b Peaks tentatively identified by co-elution with standards.
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Dietary BNF at either dose resulted in morphological changes in the intestine o f 
catfish. Thinning o f the submucosa with submucosal separation were perceptible, as 
well as increase in Goblet cell numbers (Figure 3.4). Morphological changes were 
more evident with the higher BNF treatment (50 mg BNF/kg diet).
DISCUSSION
These studies demonstrated that 1.9 to 2.6 % of the total [14C]-TCB dose was 
absorbed in the in situ  intestinal preparations during the 60-min perfusion. Taking into 
consideration the short duration of exposure and limited intestinal surface area (only a 
fraction of the intestine was used in the in situ  perfusion), the amount of [l4C]-TCB 
which reached the systemic circulation was appreciable. Under in vivo conditions, 
dietary xenobiotic exposures need to be examined in context with digestive processes, 
since xenobiotics are usually ingested in association with food (James and Kleinow, 
1994). Typically, shorter transit times of foodstuffs in the intestine result in decreased 
xenobiotic bioavailability (Watkins, III and KJaassen, 1997). Gastrointestinal transit 
times longer than one hour are likely to be seen under in vivo conditions, suggesting 
that chemical uptake would be much higher than seen in the present study. Studies by 
Lane and Jackson (1969) have estimated that 24 to 36 hours (at 12°C) are needed for 
catfish to completely empty their digestive tracts after a meal.
Similar amounts o f [I4C]-TCB were absorbed for all treatments, suggesting 
that BNF exposure at either dose did not influence TCB transfer from the lumen to the 
systemic circulation. Likewise, similarity in TCB gradients across the postinfusate to 
mucosa and mucosa to blood interfaces further support this contention. The greatest
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BFigure 3.4 - Proximal intestine of (A) control catfish (160x) and (B) catfish exposed to 
50 mg BNF/kg diet for 10 days (63x). Intestine o f catfish treated with BNF display 
thinning and separation of submucosa (SM), and increase in number o f  goblet cells
(G).
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TCB Meq concentration gradients seen were between mucosa and blood (21.7 to 
23.6x), and were consistent across treatments. Concentration gradients between 
postinfusate and mucosa (1.3 to 2.6x), although less consistent for all treatments, were 
overall much smaller. This pattern o f TCB distribution in the compartments o f the in 
situ preparations were previously attributed to the relative lipid content o f the different 
compartments (Doi et al., 2000). These results would suggest that TCB transfer from 
the mucosa to the blood is the rate limiting factor in the overall systemic uptake of 
TCB from the intestinal lumen. It is possible that the TCB transfer through the mucosa 
is dependent on cytosolic transporters, which would limit chemical transfer rate to the 
blood. Cytosolic transporters of lipophilic xenobiotics have been identified, and 
include glutathione-S-tranferase (Dixit et al., 1982), lipoproteins (Vetter et al., 1985), 
and fatty acid binding proteins (Larsen et al., 1991). The contribution o f these 
mechanisms to the systemic bioavailability o f  TCB is only speculative at this time.
Previous studies in catfish by James et al. (1996), utilizing in situ conditions 
identical to the present study, have shown that BNF pretreatment (10 mg BNF/kg diet 
for at least 2 weeks) did not affect either the biotransformation or bioavailability of 
dietary BaP metabolites, including 3-OH-BaP and two conjugated compounds (BaP-9- 
sulfate and 9-benzo(a)pyrenyl-p-D-glucopyranosiduronic acid). In both controls and 
BNF-treated animals, the two conjugated BaP metabolites were absorbed as 
administered (without prior metabolism), while 3-OH-BaP was metabolized prior to 
absorption. Contrasting results were seen in similar in situ preparations examining the 
uptake and metabolism of parent BaP (Kleinow et al., 1998). In the latter study, BNF
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treatment altered the metabolite profile of BaP, and increased the amounts of parent 
BaP and unconjugated metabolites that were transferred to the systemic circulation. 
Systemic bioavailability o f BaP Meq was shown to increase 2.6 to 5.5-fold with BNF 
exposure, but metabolites accounted for only 10.2 to 23.1% of the total increase. These 
results suggested that BNF preexposure modulated the bioavailability o f parent BaP 
through effects that included, but were not restricted to BaP metabolism. Although not 
investigated, the possibility that BNF exposure could have some effect on the 
intestinal permeability o f xenobiotics through non-specific toxicity was discussed by 
the authors (Kleinow et al., 1998).
BNF dietary exposure has been formerly shown to cause both structural 
(reduction in body weight, epithelial hyperplasia in the gills and fins) and biochemical 
(increase in hepatic microsomal phospholipid) alterations in fish (Harris et al., 1988; 
Grady et al., 1992). The present study demonstrated that dietary BNF administration at 
10 mg, but more markedly at 50 mg BNF/kg diet, resulted in morphological changes in 
the intestine, including thinning and separation of the submucosal layer, as well as an 
increase in the number o f Goblet cells. The morphological alterations described herein 
held remarkable similarity to the structural changes related to TCB exposure seen in 
previous studies (Doi et al., 2000), indicating that these may not be chemical-specific. 
The lack o f  effect of BNF exposure on the bioavailability of [l4C]-TCB in the present 
study, despite the observed morphological effects, suggest that these structural changes 
are not likely to influence the transfer of xenobiotics across the intestine.
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In earlier studies in our laboratory, TCB preexposure at both 0.5 and 5 mg 
TCB/kg diet resulted in significant decreases in the systemic bioavailability of a sub­
sequent and similar [14C]-TCB dose (Doi et al., 2000). Changes in [l4C]-TCB 
bioavailability did not correlate to metabolism, as TCB pretreatment, in a similar 
manner to BNF exposure in the present study, had no significant effect on [i4C]-TCB 
metabolism during the 60-min perfusion. A couple of factors associated to TCB 
exposure were forwarded as potential modulators o f the intestinal permeability of 
[14C]-TCB, including decreases in the diffusion gradient (by increases in tissue loads), 
and non-specific toxicity (morphological changes similar to those described herein 
were seen in catfish given 0.5, but mostly 5 mg TCB/kg diet for 10 days) (Doi et al., 
2000). It is probable that structural changes caused by TCB preexposure had a minor 
role in the modulation o f [I4C]-TCB uptake in previous studies, considering that like 
alterations in the present study had no effect on the bioavailability of [l4C]-TCB. 
These conclusions reinforce previously discussed assumptions that the effect of TCB 
preexposure on the subsequent bioavailability of [14C]-TCB is more likely to be 
diffusion-related (Doi et al., 2000). Decreased dietary PCB uptake following previous 
dietary and dermal (contaminated sediments) exposures have been demonstrated 
experimentally (Hansen et al., 1976; Dabrowska et al., 1996), and modeled by Barber 
et al. (1991) and Clark et al. (1990).
Intestinal AHH activity was significantly increased 9.2- and 12.5-fold 
following pretreatment with 10 and 50 mg BNF/kg diet, respectively. AHH activity 
has been shown to correlate in a linear fashion to CYP1A content in intestinal
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microsomes o f catfish (Doi et al., 2000), however, total CYP content did not correlate 
to AHH with BNF treatment These results corroborate the previous assumption that 
CYP1A probably corresponds to a small fraction o f total CYP content in intestinal 
microsomes o f catfish (James et al., 1997; Doi et al., 2000). A comparison between 
catfish and a number of other fish species have shown that intestinal CYP1A activities 
are considerably lower in catfish (Van Veld et al., 1988a; Van Veld et al., 1988b; Van 
Veld et al., 1991; James et al., 1997; Kleinow et al., 1998). These differences appear to 
be not only species-related, but also influenced by experimental differences including 
the composition of the diet (Rosenberg, 1991; James et al., 1997). Intestinal AHH 
activity for control animals fed a semi-synthetic diet reported herein (1.24 ± 1.08 
pmol/min/mg protein) were comparable to previous reports (3.9 ±1 .9  pmol/min/mg 
protein) (James et al., 1997). Increased AHH activities had been reported for animals 
fed a commercial chow (approximately 6-fold), or a commercial chow with BNF 
(approximately 18-fold) (James et al., 1997). The relative AHH induction in animals 
treated with 10 mg BNF/kg diet with the semi-synthetic diet (9.2x), as seen in the 
current study, was higher than observed with commercial chow (3 to 5.6-fold) (James 
et al., 1997; Kleinow et al., 1998). These results stress the importance of utilizing 
controlled experimental designs (semi-synthetic diet, depuration o f wild-caught 
animals) for establishment of basal levels of inducible enzymes, as well as for 
interespecies comparison of relative induction effects of xenobiotics.
[I4C]-TCB was metabolized to a small degree in the intestine o f catfish over 
the duration o f the in situ intestinal preparation. TCB metabolism was highly variable
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among individuals, with metabolites representing between 0.54 to 1.27% of total 
[,4C]-TCB Meq recovered in mucosal extracts. There was no effect of BNF 
pretreatment on the extent and profile o f mucosal TCB metabolism in catfish, which 
consisted of nearly equal amounts of two tentatively identified metabolites, 2-OH- 
3,4,3’,4'-TCB and 4-OH-3,5,3’,4’-TCB, for all treatments. Studies in rats have shown 
that parenteral BNF administration induces hepatic formation o f TCB hydroxylated 
metabolites (4-OH-3,5,3',4’-, 5-OH-3,4,3’,4’-, and 6-OH-3,4,3’,4’-TCB), most likely 
as a result of CYP1A induction (Morse et al., 1995b). A similar dependence of TCB 
metabolism upon CYP1A was hypothesized in a study with scup, where changes in 
TCB metabolite profile (decrease in 5-OH-3,4,3’,4’-TCB formation) were shown to be 
dose-dependent, presumably caused by the inhibitory effects o f the high TCB dose on 
CYP1A activity (White et al., 1997). It is not clear whether or not CYP1A is 
exclusively involved in the metabolism of TCB in the catfish intestine. Increases in 
AHH activity following BNF administration were not correlated to significant 
alterations in TCB metabolism. These findings are consistent with a CYP1A- 
independent pathway of TCB metabolism in the catfish intestine. Alternatively, the 
lack o f BNF-treatment effect on TCB metabolism could be related to the slow 
metabolism rate o f TCB. White et al. (1997) have shown that the rates o f in vitro TCB 
hepatic metabolism in scup are 2,000 to 4,000 times lower than benzo(a)pyrene 
metabolism rates in the same species (Stegeman et al., 1981). In addition, even though 
CYP1A levels were increased in the catfish intestine, it is possible that they were not 
high enough to influence TCB metabolism in the 60 min course o f the in situ
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preparation. AHH activities induced by BNF exposure herein were much lower (21 to 
63 x) than AHH activities o f a number of other fish species, including spot and 
toadfish (320 to 720 pmol/min/mg protein) following exposure to CYP1A inducers (3- 
methylcholanthrene and benzo(a)pyrene) (Van Veld et al., 1988a; Van Veld et al., 
1988b). It remains to be determined whether the lack o f effect of BNF exposure on 
TCB metabolism is related to CYPlA-independence or to slow rates of CYP1A 
metabolism.
The percentages of the total [UC]-TCB Meq recovered as metabolites were not 
significantly different for the mucosa (0.54 to 1.27%), postinfusate (0.24 to 0.37%), 
and blood (1.00 to 1.58%). Similar to mucosal extracts, nearly equal amounts o f  2- 
OH-3,4,3’,4’-TCB and 4-OH-3,5,3’,4’-TCB were found in the postinfusate, for all 
treatments. Interestingly, significantly lower amounts o f 4-OH-3,5,3',4'-TCB were 
found in the blood o f those animals treated with BNF, while no difference was evident 
for 2-OH-3,4,3’,4’-TCB. It appears that the systemic bioavailability of 4-OH-3,5,3\4'- 
TCB is decreased in BNF-treated animals, but no corresponding increases on the 
amounts of this metabolite are evident both in the mucosa and postinfusate of 
corresponding treatments. It is possible that the intestinal permeability o f 4-OH- 
3,5,3',4-TCB is somehow changed by BNF exposure, but the mechanism o f this 
response will need further investigation. Studies in rodents have shown that 4-OH- 
3,5,3’,4'-TCB is the only metabolite to accumulate in rodent plasma (Brouwer et al., 
1990; Morse et al., 1995a; Damerud et al., 1996), mainly due to 4-OH-3,5,3',4'-TCB 
competitive binding to transthyretin, a plasma thyroid hormone-binding protein
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(Brouwer and van den Berg, 1986; Damerud et al., 1996). Thyroid hormone-binding 
proteins have been identified in fish species (Larsson et al., 1985; Yamauchi et al., 
1999), but it is not known whether or not such proteins are affected by BNF, or if  they 
interact with 4-OH-3,5,3',4'-TCB in fish. The significance o f the decreases in blood 
amounts of 4-OH-3,5,3',4'-TCB following BNF exposure remain to be clarified.
A higher percentage of total TCB metabolites could be seen in intestinal 
mucosa following BNF preexposure (0.54 to 1.27%) as compared to previous studies 
in our laboratory where TCB pretreatment resulted in 0.35 to 0.59% of metabolites 
(Doi et al., 2000). Composite differences in amounts of mucosa TCB metabolites were 
accompanied by corresponding lower levels in postinfusate total TCB metabolites for 
BNF- (0.33 to 0.37 %) in comparison to TCB-pretreated animals (0.51 to 0.59%), and 
appear to be related mainly to the levels o f  4-OH-3,5,3',4'-TCB. Pretreatment with 
dietary TCB appears to favor the formation of 2-OH-3,4,3’,4’-TCB in comparison to 
4-OH-3,5,3',4'-TCB (the latter being detected in only 3 of 10 mucosal samples of 
treated animals) (Doi et al., 2000). The present study suggests that BNF exposure, 
contrary to TCB, results in formation of nearly equal amounts o f  both metabolites. 4- 
OH-3,5,3',4'-TCB is thought to be formed through the rearrangement o f a 4,5-epoxide 
(Klasson Wehler et al., 1989; White et al., 1997), but little is known regarding the 
pathways of 2-OH-3,4,3’,4’-TCB formation. It has been hypothesized that a CYP other 
than CYP1A may be responsible for the formation of the 4,5-epoxide intermediate 
(White et al., 1997), and that this pathway would be favored when CYP1A levels 
decrease. It is possible that TCB preexposure resulted in the induction o f a CYP other
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than CYP1A (AHH activity levels were not induced at 0.5 mg TCB/kg diet, and 
showed induction but high variability at 5 mg TCB/kg diet), which would explain the 
lower levels o f 4-OH-3,5,3',4’-TCB following TCB pretreatment. Conversely, BNF 
exposure resulted in significant increases in AHH activity, previously shown to 
correlate to increased CYP1A levels in the catfish intestine (Doi et al., 2000), which 
would in turn favor the 4,5-epoxide pathway resulting in formation o f 4-OH-3,5,3’,4'- 
TCB.
In conclusion, these studies have shown that (1) first pass intestinal metabolism 
appears to be a minor contributor to the total metabolism of dietary TCB, with the 
formation of small amounts o f tentatively identified 2-OH-3,4,3’,4’-TCB and 4-OH- 
3,5,3',4'-TCB, (2) there was no significant correlation between induction of AHH 
activities by BNF pretreatment and the extent and profile of TCB metabolism, (3) 
induction of AHH related activities in the intestine following BNF exposure was not 
correlated to the systemic uptake of a subsequent [l4C]-TCB exposure, and (4) dietary 
BNF caused morphological alterations in the intestine of catfish (especially at the 
higher BNF dose examined) without affecting subsequent TCB uptake.
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CHAPTER 4: P-GLYCOPROTEIN IN THE CATFISH 
INTESTINE: DEDUCIBILITY BY XENOBIOTICS AND 
FUNCTIONAL PROPERTIES
INTRODUCTION
P-glycoprotein (pgp) is a membrane bound 170 kDa protein that has been 
extensively studied in mammals as the mediator for tumor cell multidrug resistance 
(MDR). Increases in tumor pgp expression confer drug resistance through energy- 
driven efflux transport, which prevents intracellular accumulation o f unrelated cyto­
toxic drugs, including Vinca alkaloids, paclitaxel (Taxol™), and anthracyclines, to 
name a few (Dano, 1973; Juliano and Ling, 1976; Bradley et al., 1988; Ford and Hait, 
1990). While often overexpressed in tumors, pgp can be found in nontransformed 
tissues as well. Localized pgp expression has been described in various tissues, 
including intestinal epithelium, liver bile canaliculi, kidney proximal tubules, adrenal 
cortex, and brain capillaries (Thiebaut et al., 1987; Cordon-Cardo et al., 1990). A 
physiological role for pgp is yet to be uncovered, but its distribution in organs with 
specialized excretory, secretory, and barrier functions is consistent with a postulated 
protective role against toxic insult (Gottesman and Pastan, 1988; Ford and Hait, 1990; 
Schinkel, 1997).
A pgp-mediated multixenobiotic resistance (MXR) mechanism has been 
associated with modulation o f xenobiotic accumulation and the ability of aquatic 
animals to live and thrive in contaminated environments (Kurelec, 1992; Epel, 1998). 
Studies in fish have shown that the MXR mechanism resembles the mammalian MDR 
in many ways. Partial cloning o f  two pgp genes identified in winter flounder have
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shown that fish pgps are homologous to mammalian MDR (Chan et al., 1992). In 
addition to genetic correlation, cross-reactivity with mammalian pgp antibodies have 
shown that the distribution of pgp in fish tissues is consistent with patterns seen in 
mammals, including organs such as the gut, liver, and kidney (Hemmer et al., 1995; 
Hemmer et al., 1998; Kleinow et al., 2000). Indication o f functional similarities have 
also been provided by studies in killifish, where active transport o f the known pgp 
substrate cyclosporine was shown to occur in renal tubules (Schramm et al., 1995).
The gastrointestinal tract appears to be a major route o f  contaminant uptake for 
fish species. There are indications in mammals that pgp may modulate the intestinal 
bioavailability o f dietary drugs and xenobiotics, through efflux activity back into the 
intestine. Polarized basolateral to apical ATP-dependent pgp-mediated flux in human 
colonic adenocarcinoma cell lines has been demonstrated for a number of pgp sub­
strates, including vinblastine (Terao et al., 1996) and rhodamine (Yumoto et al., 1999). 
In vitro and in vivo studies in mice (van Asperen et al., 1997), rats (Barthe et al., 1998; 
Yumoto et al., 1999), and humans (Lown et al., 1997) have further demonstrated that 
the intestinal absorption o f drugs, including paclitaxel, cyclosporine and digoxin, may 
be increased with concurrent administration of inhibitors (e.g. verapamil), which block 
pgp-mediated transport back into the intestinal lumen.
Common chemical characteristics which determine substrate specificity for pgp 
are mostly unidentified, with the exception of moderate hydrophobicity (West, 1990; 
Bain and LeBlanc, 1996; Sharom, 1997). Environmental contaminants identified as 
potential substrates for pgp in aquatic species include 2-acetylaminofluorene (AAF),
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the hydrophobic xenobiotics Aroclor 1254, DDT, DDD, and DDE, and the 
hydrophobic pesticides dacthal, chlorbenside, sulfallate and pentachlorophenol 
(Kurelec and Pivcevic, 1991; Cornwall et al., 1995; Waldmann et al., 1995; Galgani et 
al., 1996; Kurelec et al., 1996). Studies in gill tissues o f mussels and clams have 
shown that the pgp inhibitors verapamil and staurosporin modulate AAF accumulation 
(Kurelec and Pivcevic, 1991; Waldmann et al., 1995; Kurelec et al., 1996), and that 
hydrophobic xenobiotics and pesticides inhibit the efflux o f the pgp substrate 
rhodamine, in a species-specific manner (Cornwall et al., 1995; Galgani et al., 1996). 
Evidence suggests that hydrophobic environmental contaminant benzo(a)pyrene (BaP) 
may be transported by pgp as well. Verapamil-sensitive efflux o f BaP in tumor MDR 
cell lines (Yeh et al., 1992) and in membrane vesicles o f human intestinal epithelium 
(Penny and Campbell, 1994), as well as autoradiographic evidence in the channel 
catfish intestine, are consistent with a pgp modulatory role in the intestinal uptake of 
BaP (Kleinow et al., 1996).
A degree of overlap in pgp and cytochrome P450 inducers and substrate speci­
ficity, as well as coincidence in the tissues where they are expressed, has lead to the 
hypothesis that these two systems may exert complimentary protective functions 
against xenobiotics (Burt and Thorgeirsson, 1988; Gant et al., 1991; Schuetz et al., 
1996). Studies have shown that pgp induction occurs in rat liver cells following 
exposure to cytochrome P4501A (CYP1 A) inducers, including the polycyclic aromatic 
hydrocarbons BaP and 3-methylcholanthrene (3-MC) (Gant et al., 1991; Chieli et al., 
1994; Fardel et al., 1996). Likewise, in vivo studies in rats have shown co-induction of
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hepatic pgp and CYP1A following exposure to 3-MC and the carcinogen AAF (Burt 
and Thorgeirsson, 1988; Gant et al., 1991; Tateishi et al., 1999). The relationship 
between hepatic pgp and CYP1A has been examined to a limited extent in fish. 
Blennies exposed for 3 weeks to sediment and food contaminated with crude oil (rich 
in polycyclic aromatic hydrocarbons), showed increases in hepatic levels of both pgp 
and CYP1A (Bard et al., 1998). In another study, a 3-day exposure to low aqueous 
levels of hydrocarbon-rich Diesel-2 oil resulted in no alteration in carp hepatic CYP1A 
activity. However, when the pgp inhibitor verapamil was added to contaminated water, 
hepatic CYPlA-related activity was induced following 2 days of exposure, indicating 
that verapamil inhibited pgp-mediated xenobiotic efflux, increasing the uptake o f 
Diesel-2 oil (Kurelec, 1995).
The purpose o f the present study was to characterize the MXR response in the 
catfish intestine, following dietary exposure to environmental pollutants and prototypic 
MDR inducers (Figure 4.1). Vincristine (VIN) and p-naphthoflavone (BNF) were 
selected as prototypic pgp and CYP1A inducers, respectively (Bradley et al., 1988; 
Licht et al., 1991; James et al., 1997; Kleinow et al., 1998). BaP and 3,4,3\4’-tetra- 
chlorobiphenyl (TCB) were selected according to their environmental relevance, as 
well as for their CYPlA-inducing abilities (Van Veld et al., 1988a; Van Veld et al., 
1988b; Doi et al., 2000) and potential as pgp substrates (BaP) (Yeh et al., 1992; Penny 
and Campbell, 1994). The specific objectives of these study were (1) to examine the in 
vivo effect of the prototypic pgp inducer VIN and the CYPlA-inducers BNF, TCB, 
and BaP upon detectable intestinal C219 immunoreactivity, and (2) to evaluate
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Figure 4.1- Compounds associated with p-glycoprotein mediated resistance mecha­
nisms.
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functional activity of membrane vesicles obtained from the catfish intestine, using the 
prototypic pgp substrate vinblastine, and the known pgp inhibitor verapamil.
MATERIALS AND METHODS 
CHEMICALS
3,4,3’,4’-Tetrachlorobiphenyl was obtained from ChemService Inc., West 
Chester, PA. Tricane methane sulfonate (MS-222™) was purchased from Argent 
Chemical Company, Redmond, WA. Electrophoresis material including acrylamide, 
bis N,N’-methylene-bis-acrylamide, 10X TBS, Tween-20, gelatin, nitrocellulose, 
Kaleidoskope Prestained Standards and the Immun-Blot™ Assay Kit with Goat Anti­
mouse IgG Alkaline Phosphatase (GAM-AP) were acquired from Bio-Rad 
Laboratories, Hercules, CA. The C-219 murine monoclonal antibody was purchased 
from Signet Laboratories Inc., Dedham, MA. Radiolabeled [3H]-vinblastine was 
obtained from Amersham Life Sciences, Inc., Arlington Heights, IL. All other 
chemicals were purchased from Sigma Chemical Co., St. Louis, MO.
EXPERIMENTAL ANIMALS 
Channel catfish, Ictalurus punctatus, o f both sexes were obtained from the 
Louisiana State University Aquaculture Research Station, Baton Rouge, LA. All 
animals were acclimated for at least 4 weeks, under a 12-h light/dark photoperiod, 
under flow through conditions with dechlorinated tap water (pH 8.0 ±  0.2, temperature 
19.4 ± 0.9°C, total hardness 29.2 ± 6.9 mg CaC0 3 /l, alkalinity 142.1 ± 15.1 mg/1), and 
treated in accordance with National Institute o f Health guidelines prior and for the 
duration o f the experimental period.
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DIETARY TREATMENTS
Three separate experiments were conducted in order to examine the effects of 
dietary CYP1A inducers and vincristine on pgp-related reactivity using immunoblot 
analysis. These studies examined varying doses, modes o f administration, and types of 
diet, as follows:
Experiment I: Dose Response with CYP1A Inducers 
In this first experiment, the effects of different doses o f dietary BNF, BaP, and 
TCB were investigated. Fish weighing 342 ± 68 g (n = 42) were divided into groups of 
six fish. A custom, purified, semi-synthetic diet composed of casein 32%, dextrin 
29.8%, cellulose 19%, soybean oil 3%, Menhaden oil 3%, gelatin 8%, salt and vitamin 
mix 5%, and choline chloride 0.2% (Dyets Inc., Bethlehem, PA) was used as the base 
diet for all treatments. Semi-synthetic diet was coated with com oil (1 ml com oil/100  
g diet) with or without chemical additions, and fed ad libitum  to animals for 10 days, 
at a rate of 1% body weight Groups of catfish were fed com-oil coated diets 
containing (1) no additions (controls), (2) BNF at 10 or 50 mg/kg diet, (3) TCB at 0.5 
or 5 mg/kg diet, or (4) BaP at 1 or 10 mg/kg diet. All diets were prepared prior to the 
beginning of the experimental period and kept at -20°C. Diets containing BaP were 
additionally kept under nitrogen and protected from light to prevent oxidation and 
photodecomposition.
Experiment 2: CYP1A Inducers Via Indwelling Stomach Tube 
To ensure consistency in dose administration so to eliminate variability associ­
ated with the amounts o f food ingested, fish in the second experiment were outfitted
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with indwelling stomach tubes. Fish were anesthetized with MS-222 buffered with
NaHCC>3~ (induction and maintenance doses o f 106 and 86  mg/1, respectively) 24 to 48 
h before diet administration, to facilitate stomach tube installation as described in 
Kleinow (1991). The stomach tube consisted of 3 pieces: (1) an 8 cm piece o f Intra­
medic™ PE- 320 tubing (Becton Dickinson & Co., Parsippany, NJ) angled at approxi­
mately 80° which is inserted through the snout, (2) a piece o f IV tubing advanced into 
the stomach at the level of pectoral fins, and (3) a ~ 53 cm piece of latex tubing (1/8”
I.D. x 3/16” wall thickness) attached to the dorsal external extension of the angled PE 
tubing (Figure 4.2). The latex tubing was sutured to the dorsal -fin for stability and 
plugged distally providing buoyancy when filled with air.
Experimental diets were prepared by evenly distributing the chemicals in a 
toluene carrier over semi-synthetic diet which was finely ground. Solvent-moist diet 
was protected from light and dried until the solvent was completely evaporated. Diets 
were thoroughly rolled and mixed prior to storage at -20°C (BaP diet was additionally 
kept under nitrogen and protected from light during storage). Immediately prior to 
gavage administration, diets were mixed with water (1:2.5) producing a slurry 
compatible with the gavage tube. Four groups of fish (n = 4, 1,502 ± 403 g) were 
administered the appropriate gavage slurry of the semi-synthetic diet containing ( 1) 
control diet without additions, (2) BNF at 200 mg/kg diet, (3) BaP at 40 mg/kg diet, or 
(4) TCB at 20 mg/kg diet. Fish were treated for 10 days, at a daily rate o f 0.25% body 
weight, divided in two aliquots, administered through the gavage tube twice a day.
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Figure 4.2- Schematic representation o f stomach tube placement in channel catfish.
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Experiment 3: (3-Naphthoflavone and Vincristine
This last experiment examined the effect of prototypic CYP1A and pgp induc­
ers on pgp-related expression in the intestine of catfish. Conditions in this section 
attempted to replicate the dosing protocol of an earlier study which investigated pgp 
induction in the catfish intestine by the same inducers using immunohistochemistry 
analysis (Kleinow et al., 2000). Fish weighing 1,453 ± 366 g (n = 14) were divided 
into 3 groups of either 4 or 5 fish. Commercial fish feed (Silver Cup trout pellets, 
Nelson & Sons Inc., Murray UT) was used as the base diet for all treatments. Control 
and BNF diets were prepared by coating the commercial chow with com oil (1 ml com 
oil/lOOg diet). Control diets were prepared with pure com oil. BNF diets were coated 
with com oil at 10 mg BNF/kg diet. VIN diets (20 pg/kg diet) were prepared by 
spraying an aqueous VIN solution over the diet, which was dried at room temperature 
before feeding. Animals were given the appropriate experimental diet ad libitum for 16 
days, at a rate of 3% body weight.
MEMBRANE VESICLE PREPARATION 
Following termination o f exposure, fish were fasted for 24 h prior to tissue 
collection. Fish were sacrificed, and the whole intestine was harvested. Intestine was 
divided in two sections, and the most proximal discarded, based on earlier studies, 
which indicated that pgp-related levels and responsiveness to dietary inducers are 
greater in the distal intestine o f catfish (Kleinow et al., 2000). Distal intestine was 
promptly rinsed with cold modified Sack’s preservation buffer (5 mM KH2PO4, 14 
mM NaHCC>3, 54 mM K2HPO4, 5.9 mM KHCO3, and 205 mM mannitol). The
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intestinal section was then cut open, thoroughly rinsed with cold Sack’s buffer, and 
blotted dry. Intestinal mucosa was scraped using the edge o f a glass slide. Intestinal 
mucosa o f randomly paired animals from like treatment groups were pooled for vesicle 
preparation to ensure adequate sample size in experiment 1. Intestinal mucosa of 
individual animals were used for the remaining experiments. Aliquots of liver tissue (~ 
2 g) were harvested following removal o f intestine, and processed similarly to mucosa, 
when collected. Because protocols for immunoblot detection of pgp in fish tissues are 
available only for liver (Cooper et al., 1996), hepatic vesicles were used in the present 
study as validation for the method developed for intestinal tissues. Tissues were 
homogenized in plasma membrane buffer (5 mM Tris-HCl, pH 7.5, 0.25 M sucrose, 
0.2 mM magnesium chloride) containing 0.1 pM PMSF and 1 mM EDTA. For 
experiments 2 and 3, PMSF was substituted by 50 pi protease inhibitor cocktail/g 
tissue (Protease inhibitor cocktail, Sigma Chemical Co., St. Louis, MO), which 
contained 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), pepstatin A, 
transepoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64), bestatin, leupeptin and 
aprotinin. The homogenate was centrifuged at 1,000 x g for 10 min at 4°C to sediment 
nuclei and intact cells. The supernatant was saved, and the pellet was resuspended in 
plasma membrane buffer and re-centrifuged. Supernatants from both runs were 
combined, and centrifuged at 15,000 x g  for 20 min at 4°C to sediment mitochondria 
and lysosomes. Resulting supernatants were centrifuged at 100,000 x g  for 1 h at 4°C 
to sediment plasma membrane vesicles and endoplasmic reticulum. Final pellets were 
resuspended in plasma membrane buffer and stored at -80°C until analysis.
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WESTERN BLOT ANALYSIS
Mixed membrane vesicles were subjected to SDS-PAGE, electrophoretic 
transfer to nitrocellulose and immunoblotting procedures for the detection of pgp. 
Membrane vesicles quantitated according to Lowry (Lowry et al., 1951) were solubi­
lized (1:5) in sample buffer consisting of either (1) 62.5 mM Tris, pH 6 .8, 2% SDS, 
10% glycerol, 5% p-mercaptoethanol, and 0.001% bromophenol blue (heated at 95°C 
for 4 min) (experiment 1), or (2) 62.5 mM Tris, pH 6 .8 , 2% SDS, 10% glycerol, and 
0.001% bromophenol blue (room temperature for 20 min) (experiment 2 and 3). After 
solubilization, vesicles (16 pg or 30 pg) were loaded on a 7.5% acrylamide/bis-acryla- 
mide gel and electrophoresis performed at a constant voltage o f 200V on a Bio-Rad 
Mini-protean™ II Dual Slab Cell, using a 25 mM Tris-HCl, pH 8.3, 192 mM glycine, 
and 0.1% SDS running buffer. Following electrophoresis, proteins were transferred to 
a 0.45 pm nitrocellulose membrane using a Bio-Rad Mini Trans-Blot™ 
Electrophoretic Transfer Cell. Transfer was performed at 100V for 2 h, using a 25 mM 
Tris, pH 8.3, 192 mM glycine, 20% v/v methanol transfer buffer. After transfer, 
immunoassay was performed using the mammalian C-219 monoclonal antibody and 
the Bio-Rad Immun-Blot™ Assay Kit with Goat Anti-mouse IgG Alkaline 
Phosphatase (GAM-AP). The nitrocellulose membrane was washed twice in Tris- 
buffered saline (TBS) (20 mM Tris, pH 7.5, 500 mM NaCl) for 5 min. Washes were 
followed by 1-h blocking with a 3% gelatin in TBS solution and a 5-min TTBS 
(0.05% Tween-20 in TBS) wash. Membranes were then incubated overnight with C- 
219 (0.2 pg/ml) in antibody buffer ( 1% gelatin in TTBS), followed by two washes in
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TTBS for 5 min. Following overnight incubation with C219, a 90-min conjugate 
binding with a 33% solution o f GAM-AP in antibody buffer was performed. Five-min 
washes were performed twice with TTBS and once with TBS. Color developer used to 
detect immunoreactivity consisted o f a mixture of two reagents in water, one 
containing nitroblue tetrazolium in aqueous dimethylfonnamide with magnesium and 
another consisting of 5-bromo-4-chloro-3-indoyl phosphate. Prestained Standards 
where used for molecular weight determination, and contained the dye bound 
molecular weight markers calibrated for each lot: myosin, p-galactosidase, and bovine 
serum albumin. Quantitation o f the signal was performed using computerized 
densitometry o f scanned images (ScanJet 4C, Hewlett-Packard, Greeley, CO). Relative 
density o f the immunoreactive band was measured using the public domain NIH Image 
program (developed at the U.S. National Institutes of Health and available on the 
internet at http://rsb.info.nih.gov/nih-image/). Correction of inter-gel variability was 
performed by measurement of a standard sample loaded in all gels.
The mammalian C219 monoclonal antibody was selected for these studies for 
its specificity. This antibody recognizes highly conserved cytoplasmic amino acid 
sequences that have been identified in MDR proteins (Kartner et al., 1985). Successful 
detection of pgp-related proteins with C219 have been described in mussels (Cornwall 
et al., 1995; Galgani et al., 1996), clams (Waldmann et al., 1995), fish (Hemmer et al., 
1995; Hemmer et al., 1998), as well as in a wide variety of mammalian species 
(Cordon-Cardo et al., 1990; Georges et al., 1990; Beaulieu et al., 1997).
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FUNCTIONAL ANALYSIS
Transport assays were performed with membrane vesicles from animals treated 
with BNF (50 mg/kg diet) or VIN (20 pg/kg diet), and respective controls. Experi­
ments were performed using the prototypic pgp substrate [3H]-vinblastine (VBL), and 
the known inhibitor verapamil (VP), following a previously described method devel­
oped for multidrug resistant cell lines (Horio et al., 1988).
Vesicles o f control (22 or 50 pg), BNF-treated (13 pg) or VIN-treated (50 pg) 
animals were incubated with 8 nM [3H]-VBL (specific activity 12.5 Ci/mmol, 13.7 
mCi/mg) solution in transport buffer (10 mM Tris-HCl, pH 7.5, 0.25 M sucrose) in a 
final volume of 100 pi at 25°C in a shaking incubator for 20 min. The incubation was 
carried out with one o f the following additions: ( 1) Transport buffer containing MgCl2 
(10 mM), (2) Transport buffer containing MgCl2, ATP (3 mM) or ATP (ImM) with an 
ATP regenerating system that included creatine phosphate (CP) (3 mM) and creatine 
kinase (CK) (30 pl/ml), or (3) Transport buffer containing MgCl2, ATP (or ATP with 
the regenerating system), and verapamil (VP) (5 pg/ml). After a 20-min incubation, 
the reaction was stopped by addition of 1 ml o f  ice-cold transport buffer. This solution 
was filtered under vacuum, through 0.2 pm nylon filters (Alltech Associates Inc., 
Deerfield, IL) presoaked in 10% fetal calf serum to decrease non-specific binding. 
Filters were washed twice with 4 ml o f ice-cold transport buffer, and oven dried at 
50°C for 10 min. Following addition of 10 ml o f Ultima Gold LSC-Cocktail (Packard, 
Meriden, CT) to the filters, samples were dark adapted overnight and radioactivity (of 
vesicles trapped in the filter) was measured by liquid scintillation counting.
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Incubations of 30 sec duration, under the same conditions, were used as a determinant 
of non-specific binding to the filters. Each treatment was carried out in triplicate, using 
pooled samples obtained from 3 different animals.
STATISTICAL ANALYSIS 
Data analysis for the immunoblot sections was performed using the statistical 
software SigmaStat for Windows, version 1.0, Jandal Corporation, San Rafael, CA. 
Analysis were performed with p  < 0.05, using one-way ANOVA.
RESULTS 
WESTERN BLOT ANALYSIS 
Experiment I: Dose Response with CYP1A Inducers 
A ~ 80 kDa protein that crossreacted with C219 was detected in mixed mem­
brane vesicles o f  all chemical treatments, with control animals showing traces of 
detectable protein (Figure 4.3). Large individual variability was observed, with 
standard deviations often equal to the means. Staining intensity of the immunoreactive 
protein was highly increased in select animals following exposure to BNF, TCB and 
BaP at both dosage levels for each compound (Figure 4.3). Relative densities ranged 
from 0.04 to 0.97 for controls, 0.95 to 21.42 for animals exposed to BNF, 0 to 47.62 
for those treated with TCB, and 0.59 to 20.93 following BaP administration (Figure 
4.4). Increases in immunoreactivity levels with treatments were not significant due to 
the high variability in response (ANOVA: p  < 0.05), and did not appear to follow a 
dose-response relationship.
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Figure 4.3- A ~ 80 kDa immunoreactive protein was detected by Western Blot analysis 
using P-glycoprotein C219 monoclonal antibody (mAb) in intestinal mucosa from con­
trols and catfish treated with P-naphthoflavone (BNF) at 10 and 50 mg/kg diet, 
3,4,3 \4  ’ -tetrachlorobiphenyl (TCB) at 0.5 and 5 mg/kg diet, and benzo(a)pyrene (BaP) 
at 1 and 10 mg/kg diet. Experimental diets were administered for 10 days, at a rate of 
1% body weight. Standard markers are myosin (201 kDa), p-galactosidase (116 kDa) 
and bovine serum albumin (80 kDa). Each gel represents pooled mixed membrane 
vesicles (16 pg total protein per lane) from 2 animals for each treatment. A, B, C. 
Immunoassay detection using C219 mAb shows cross-reactivity with a protein o f ~ 80 
kDa (arrow). D, E, F. Respective blank controls (without C219) show non-specific 
immunoreactivity.
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Figure 4.4- P-glycoprotein C-219 monoclonal antibody immunoreactive protein levels 
in membrane vesicles from catfish intestine, following a 10-day dietary exposure with 
p-naphthoflavone (BNF) at 10 mg and 50 mg; 3,4,3’,4’, tetrachlorobiphenyl (TCB) at 
0.5 mg and 5 mg; and benzo(a)pyrene (BaP) at 1 mg and 10 mg (mg/kg o f diet). Each 
column represents mean ± SD (n = 6 , every two animals randomly pooled). Relative 
density was a measure o f the staining intensity of C-219 immunoreactivity corrected 
for inter-gel variability.
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Experiment 2: CYP1A Inducers Via Indwelling Stomach Tube
The methodological modifications instituted in this section were based on 
results displayed in Figure 4.5, which demonstrated that alterations in sample buffer 
(removal o f (3-mercaptoethanol and boiling) resulted in the detection o f a ~ 170 kDa 
protein in addition to the ~ 80 kDa protein. The use o f  a protease inhibitor cocktail in 
addition to changes in sample buffer resulted in the exclusive detection of a -170 kDa 
C-219 immunoreactive protein in intestinal and hepatic membrane vesicles o f all treat­
ments (Figure 4.6). Immunoreactive protein levels were higher in liver membrane 
vesicles compared to intestine. Staining intensity o f  the immunoreactive protein was 
consistent across treatments in vesicles from distal intestine following exposure to 
BNF, TCB and BaP versus controls (Figure 4.7A) (ANOVA: p  < 0.05). Likewise, no 
significant alterations in immunoreactivity were observed in hepatic samples following 
BNF, BaP or TCB exposure (Figure 4.7B) (ANOVA: p  < 0.05).
Experiment 3: (3-Naphthoflavone and Vincristine 
A -170 kDa C-219 immunoreactive protein was detected in membrane vesicles 
o f all treatments (Figure 4.8). The average staining intensity of immunologically 
related protein in the intestine following exposure to VIN and BNF was not 
significantly altered in comparison to controls, due to high interindividual variability 
(Figure 4.9) (ANOVA: p  < 0.05).
FUNCTIONAL STUDIES 
The first in vitro transport experiment demonstrated that the dynamics of VBL 
accumulation in membrane vesicles was affected by the addition of ATP as an energy
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Figure 4.5- A) Alterations in sample preparation prior to loading resulted in the 
detection of a ~ 170 kDa protein (full arrow) in addition to the — 80 kDa previously 
detected (dotted arrow) in mixed membrane vesicles of distal intestine of catfish using 
C219 monoclonal antibody (mAb). B) Control gel (no C219 mAb) shows non-specific 
binding. Experimental diets were prepared using semi-synthetic diet and were given 
for 10 days at a rate o f 1% body weight. Control diet consisted o f 10 ml com oil/kg of 
diet. BNF diet consisted o f 50 mg BNF/10 ml com oil/kg of diet. 1. Standard markers 
are myosin (201 kDa), p-galactosidase (116 kDa) and bovine serum albumin (80 kDa).
2. Control diet (n = 1), sample buffer with (3-mercaptoethanol (P-merc.), boiled (95°C 
for 4 min). 3. Control diet, sample buffer with P-merc., room temperature (23°C for 20 
min). 4. BNF diet (pooled sample from 2 animals), sample buffer with P-merc., boiled. 
5. BNF diet, sample buffer with p-merc., room temperature. 6 . BNF diet, sample 
buffer without P-merc., boiled. 7. BNF diet, sample buffer without P-merc., room 
temp.
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Figure 4.6- Western Blot analysis using P-glycoprotein C219 monoclonal antibody 
(mAb) in mucosa from distal intestine and liver o f channel catfish detected a ~ 170 
kDa protein in all treatments. Mixed membrane vesicles were obtained from controls 
(CON) and animals exposed to p-naphthoflavone (BNF) at 200 mg/kg diet, 3,4,3’,4’- 
tetrachlorobiphenyl (TCB) at 20 mg/kg diet, and benzo(a)pyrene (BaP) at 40 mg/kg 
diet for 10 days by gavage, at a rate of 0.25% body weight. Standard markers are 
myosin (218 kDa), (3-galactosidase (125 kDa) and bovine serum albumin (78 kDa). 
Each gel represents samples (16 pg total protein per lane) from individual animals for 
each treatment. A, B, C, D. Immunoassay detection using C219 mAb shows cross­
reactivity with a protein o f approximately 170 kDa (arrow). E, F, G, H. Respective 
blank controls (without C219) show non-specific immunoreactivity.
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Figure 4.7- P-glycoprotein C-219 immunoreactive protein levels in membrane vesicles 
from catfish intestine (A) and liver (B), following a 10-day dietary exposure (mg/kg of 
diet) with p-naphthoflavone (BNF) at 200 mg; 3,4,3’,4’, tetrachlorobiphenyl (TCB) at 
20 mg; and benzo(a)pyrene (BaP) at 40 mg. Each column represents mean ± SD. 
Relative density was a measure of the staining intensity of C-219 immunoreactivity 
corrected for inter-gel variability.
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Figure 4.8- Immunoblot analysis using P-glycoprotein C219 monoclonal antibody 
(mAb) in mucosa from distal intestine o f channel catfish detected a ~ 170 kDa protein 
in all treatments. Mixed membrane vesicles were obtained from controls (CON) and 
animals exposed to P-naphthoflavone (BNF) at 10 mg/kg diet or vincristine (VIN) 20 
fig/ kg diet for 16 days, at a  rate of 3% body weight. Standard markers are myosin (218 
kDa), P-galactosidase (125 kDa) and bovine serum albumin (78 kDa). Each gel 
represents samples (16 pg total protein per lane) from individual animals for each 
treatment. A, B, C. Immunoassay detection using C219 mAb shows cross-reactivity 
with a protein of approximately 170 kDa (arrow). D, E, F. Respective blank controls 
(without C219) show non-specific immunoreactivity.
140
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
__________________£ Q N ________________
kDa STD 1 2 3 4 5
2 1 8
T •%*
1 2 5  - P i
YIN
kDa STD 1
sfeflSwifcj».. - i ;
Vf*jC '..
5^t^S3E? y . .p  - - M i- - -s&nFzFS*'
BNF
kDa STD 
218
^ , : 2 W
< —
B
CQN
kDa STD 1 
218
125
.j.i*' v'=jI . „ • 'yl'
VTN
kDa STD 1 
218
125 -
BNF
kDa STD 1 
218
125 -
■».
-Is
«®r
D
141
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
<4-1
&
>O ’■4-*
p o03
33c <L><-oD e
3
<L>> B
*-3 Bca •
OS
CC (N
u
CON VIN BNF
Treatment
Figure 4.9- P-glycoprotein C-219 immunoreactive protein levels in membrane vesicles 
from catfish intestine of control animals, or following a 16-day dietary exposure of P- 
naphthoflavone (BNF) at 10 mg/kg o f diet and vincristine (VIN) at 20 pg/kg of diet. 
Each column represents mean ± SD. Relative density was a measure of the staining 
intensity o f C-219 immunoreactivity corrected for inter-gel variability.
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source, as well as by the inhibitor VP. This study utilized membrane vesicles collected 
from control and BNF-treated animals (50 mg/kg diet) from experiment 1, where 
treated animals displayed C219 crossreactivity with ~ 80 kDa protein. In control 
animals, there was a composite 7 .8-fold increase in the amount o f VBL accumulated in 
the vesicles following the addition o f ATP and the ATP regenerating system (1.56 ± 
0.32 pmol VBL/mg protein), and a 58% decrease with VP addition (0.66 ± 0.22 pmol 
VBL/mg protein) (Figure 4.10). A similar profile was seen with vesicles from BNF- 
treated animals. A composite 1.9-fold increase in the amount o f VBL accumulation 
was detected following the addition o f ATP and the ATP regenerating system (1.39 ± 
0.44 pmol VBL/mg protein), and a 81% decrease was observed with the addition of 
the inhibitor VP (0.27 ±0.17 pmol [3H]-VBL/mg protein) (Figure 4.10).
In the second in vitro transport experiment, different from the previous trans­
port study, there was essentially no transport of VBL occurring in either treatment 
group. Membrane vesicles used in this experiment were collected from control and 
VIN-treated catfish (20 pg/kg diet) from experiment 3, which displayed C219 cross- 
reactivity with - 1 7 0  kDa protein. Minimal VBL accumulation was detected in both 
treatments without and with the addition o f ATP. For both control and VIN-exposed 
animals, no VBL accumulation beyond background levels was observed (Figure 4.11).
DISCUSSION
These studies have identified in the catfish intestine a 170 kDa protein immu- 
nochemically related to the mammalian pgp. Previous immunohistochemistry studies 
have shown localized C219 reactivity in the intestinal epithelium of a number o f fish
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Figure 4.10- Characterization o f  [JH]-vinblastine (VBL) accumulation in mixed mem­
brane vesicles from distal intestine mucosa collected from controls and catfish 
exposed to (3-naphthoflavone (BNF) at 50 mg/kg o f diet for 10 days (semi-synthetic 
diet at 1% body weight, collected with PMSF). Pooled membrane vesicle protein from 
3 animals was incubated for 20 min with: a) VBL (8 nM [3H]-VBL), b) VBL + ATP (1 
mM ATP, 3 mM creatine phosphate, 30 pg/ml creatine kinase), and c) VBL + ATP + 
VP (5 pg/ml verapamil). Values are means o f  triplicate measurements. Data was 
corrected for non-specific binding (30 sec incubations).
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Figure 4.11- Characterization of [3H]-vinblastine (VBL) accumulation in mixed mem­
brane vesicles from distal intestine mucosa of catfish collected from controls and ani­
mals exposed to vincristine (VIN) at 20 pg/mg of diet for 16 days (commercial trout 
chow at 3% body weight, collected with protease inhibitor cocktail). Pooled membrane 
vesicle protein from 3 animals was incubated for 20 min with: a) VBL (8  nM [3H]- 
VBL), b) VBL + ATP (3 mM ATP), and c) VBL + ATP + VP (5 pg/ml verapamil). 
Values are means o f triplicate measurements. Data was corrected for non-specific 
binding (30 sec incubations).
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species (Hemmer et al., 1995; Hemmer et al., 1998; Kleinow et al., 2000), in a 
distribution pattern very similar to mammalian species (Thiebaut et al., 1987; Thiebaut 
et al., 1989; Cordon-Cardo et al., 1990). The catfish protein described in experiments 2 
and 3, is within the molecular weight range for C219 reactive proteins described both 
in aquatic (135 to 240 kDa) (Minier et al., 1993; Cornwall et al., 1995; Waldmann et 
al., 1995; Galgani et al., 1996) and mammalian (130 to 170 kDa) species (Kartner et 
al., 1985). The detection o f a single band in the expected molecular weight, and the 
specificity of C219, which recognizes highly conserved pgp epitopes (Georges et al., 
1990), support previous evidence from immunohistochemistry studies that indicate 
that a pgp-mediated mechanism is present in the intestine o f catfish (Kleinow et al., 
2000).
Initial immunoblot studies described herein have shown C219 reactivity with a 
protein of approximate molecular weight o f 80 kDa. A wide number of proteins 
distinct from the 170 kDa, but related to the MDR phenotype have been described 
(Vendrik et al., 1992), and C219 crossreactivity with some of these proteins, usually of 
lower molecular weight, have been demonstrated (Kawai et al., 1994). There have also 
been reports of expression of half-MDR proteins assembling as heterodimers, and 
being implicated in peptide transport (Bahrain et al., 1991). It is likely that the ~ 80 
kDa protein detected in the present studies is a degradation product o f the 170 kDa, 
considering that methodological modifications (addition of protease inhibitor cocktail 
during sample collection and changes in sample preparation) resulted in the 
disappearance o f the low molecular weight band. Fragmentation o f full-length pgp has
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been shown to occur in human pgp-containing membranes following treatment with 
trypsin, which resulted in the formation of several pgp fragments in the 30 to 60 kDa 
range (Nuti et al., 2000). The consistency and specificity o f the ~ 80 kDa band 
detection in the intestinal mucosa of catfish suggest that breakdown may be occurring 
on a specific site of the protein, which could be more susceptible in catfish than other 
species. One potential site is the linkage region of pgp, which reportedly divides the 
protein in two mirror halves, and is one o f the least conserved regions across species 
(Gros et al., 1986; Ueda et al., 1987; Gros et al., 1988; van der Bliek et al., 1988; 
Gottesman and Pastan, 1993). These assumptions, however, are only speculative at 
this time, and further studies are needed to clarify the significance o f these findings.
A noteworthy finding was that protein degradation, resulting in the detection of 
the ~ 80 kDa band was seen in samples from catfish treated with BNF, TCB, and BaP, 
but not in controls. Apparent increases in crossreactivity with the ~ 80 kDa protein in 
treated animals may have been a result o f a nearly equal cleavage of the 170 kDa pro­
tein. In control animals, gel electrophoresis of samples not subjected to boiling 
resulted in the detection o f the 170 kDa. Studies with mammalian MDR cells have 
shown that variations in electrophoretic mobility and quantitation of pgp may occur 
with variations in sample preparation and electrophoretic conditions (Greenberger et 
al., 1988). Increases in molecular mass (Greenberger et al., 1988) and formation of 
aggregates which cannot migrate in the gel (Yoshimura et al., 1989; Staats et al., 1990) 
are some of the changes that have been associated with boiling the sample prior to 
loading. For those animals that were treated in vivo with dietary BNF, TCB and BaP, a
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combination o f methodological alterations other than removal of the boiling step prior 
to electrophoresis (exclusion o f  (3-mercaptoethanol from sample buffer, and use o f a 
protease inhibitor cocktail during sample collection) were required for elimination of 
the ~ 80 kDa band. The mechanism by which in vivo exposure to the dietary 
xenobiotics examined herein altered the pgp-related protein and increased the 
susceptibility to breakdown is unknown at this time. Because breakdown was observed 
with all treatments examined, it is possible that xenobiotic exposure resulted in non­
specific intestinal toxicity, which in turn may have released additional intestinal 
proteases or potentiated their effect on intestinal tissues. Non-specific intestinal 
toxicity resulting from dietary exposure to TCB (Doi et al., 2000) and BNF (see 
Chapter 3) have been observed in the catfish intestine, but how or whether or not the 
extent o f such exposures results in alterations at the subcellular level remains to be 
investigated.
Vincristine, an anti-cancer Vinca alkaloid, has been shown to be a substrate for 
pgp in MDR cell lines (Fojo et al., 1985; Naito and Tsuruo, 1989; Sehested et al.,
1989). In addition, exposures to stepwise concentrations o f VIN have been used in the 
development of cell lines displaying varying levels o f  MDR (Licht et al., 1991). In 
vivo studies in rats have shown that intraperitoneal administration o f  VIN (1 mg/kg) 
had no effect on intestinal or hepatic MDR mRNA levels (Vollrath et al., 1994). The 
absence of significant effect of dietary VIN on pgp-related reactivity in the catfish 
intestine, in the present study, would suggest that this compound is not associated with 
intestinal pgp induction in this fish species. Early studies, however, have shown an
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apparent induction o f intestinal C219 reactivity in catfish, detected by 
immunohistochemistry and image analysis, following a comparable dietary VIN 
exposure (Kleinow et al., 2000). Differences in sensitivity and specificity between 
methods of detection could account for the observed disparity in pgp-related responses 
in catfish intestine. Immunohistochemical detection at the single-cell level has been 
shown to be a more sensitive method when compared to immunoblot, especially at low 
levels of protein expression (van der Heyden et al., 1995; Beck and Grogan, 1997). 
Another possibility is that C219 non-specific reactivity concealed pgp-related 
differences in immunoblot detection. Pgp-related immunoreactivity in the intestine is 
not exclusively restricted to the intestinal epithelium brush border where transport 
activity is thought to occur. The collection o f intestinal mucosa by scraping, as used in 
the present study may have included elements of the submucosa and muscular layers. 
Dispersed immunoreactivity to C219, apart from the epithelium, has been shown to 
occur in the catfish intestine (Kleinow et al., 2000), and studies in mammals have 
shown that C219 reacts with the heavy chain in myosin (Terao et al., 1996). Relative 
variation in myosin content in the samples, in turn, could have contributed to 
interanimal variability. The reported molecular weight o f mammalian muscle proteins 
that cross-react with C219 is in the 200 kDa range (Thiebaut et al., 1989), but non­
specific cross-reactivity with C219 in the catfish intestine has not been investigated. 
More information on cross-reactivity with C219 in fish tissues are needed for full 
evaluation of its significance on the findings here described.
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Pgp has been previously associated with a generalized stress response. 
Increases in MDR mRNA in human carcinoma cell lines were observed following 
exposure to thermal and chemical insults (e.g., sodium arsenite), a response which was 
attributed to a heat-shock responsive element in the MDR promoter region (Chin et al., 
1990b; Kioka et al., 1992). Similar observations have been made in mussels, where 
pgp-related expression (C219 immunoreactivity) and transport (verapamil-sensitive 
rhodamine accumulation) in gill tissues were modulated by exposure to thermal and 
chemical (e.g. sodium arsenite) stressors (Eufemia and Epel, 2000). It is possible that 
the pgp-related responses in the catfish intestine here described differ from earlier 
studies due to stress. While there is no evidence for such a change, animal lots may 
have been exposed to different environmental stressors, which in turn may have 
influenced the pgp-related response to subsequent xenobiotic exposures.
A great deal o f effort has been directed in the identification o f specific agents 
that induce pgp expression. The results obtained have showed that the regulation of 
pgp induction is apparently very complex, and dependent on numerous factors, includ­
ing type and length of drug exposure, species, tissues, and experimental model. For 
example, studies with rodent cell lines derived from both tumors and normal tissues 
(kidney, ileum, liver) have shown that increases in MDR mRNA occurred following 
exposure to the cytotoxic drugs adriamycin and daunomycin, but not colchicine (Chin 
et al., 1990a). MDR expression in human tissues examined in this same experiment 
were unresponsive to exposure to all cytotoxic drugs examined. In contrast, in vivo 
studies in rats have shown that parenteral exposure to colchicine, resulted in increases
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in MDR mRNA expression in liver (Vollrath et al., 1994). These induction related 
effects appear to be restricted to the liver, as similar findings were not observed in 
other organs (e.g. kidney, adrenal gland). The regulation of pgp induction by xenobiot- 
ics appears to be as complex as seen with cytotoxic drugs. BNF administration to rats 
(40 mg/kg/day i.p., for 3 consecutive days) resulted in no response in MDR expression 
in enterocytes, at the mRNA and protein levels (Lown et al., 1996). In contrast, appar­
ent induction of intestinal pgp-related reactivity was demonstrated in catfish following 
dietary BNF exposure (10 mg/kg for 16 days) (Kleinow et al., 2000). Administration 
of a chargrilled meat diet, rich in polycyclic aromatic hydrocarbons (PAHs), including 
BaP, had no effect on pgp expression in human intestine (Fontana et al., 1999), while 
BaP resulted in increased MDR mRNA levels in rat liver epithelial cells (Fardel et al., 
1996). Likewise, modulation of transport o f  pgp substrates by Diesel-2 oil (rich in 
PAHs) have been shown to occur in various aquatic organisms, including snails 
(Kurelec et al., 1995), clams (Kurelec et al., 1996), and fish (Kurelec, 1995). The 
interaction between BaP and pgp is confounding not only in regards to induction, but 
also in the ability of pgp to transport BaP. Studies in humans have shown BaP to be a 
substrate for pgp in breast cancer cells (Yeh et al., 1992) and membrane vesicles from 
intestinal epithelium (Penny and Campbell, 1994). Contrasting results were obtained 
both in vitro (using pig kidney epithelial cell lines and their derivatives which express 
MDR genes) and in vivo (using wild-type and MDR knockout mouse) where BaP 
intracellular accumulation was not affected by pgp (Schuetz et al., 1998). Inconsistent 
results were also obtained with in vitro studies in mussels examining Aroclor 1254 (a
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commercial PCB mixture which contains TCB) as a substrate for pgp transport. These 
studies, utilizing a fluorescent dye assay, have showed that Aroclor 1254 does not 
appear to influence pgp-related transport in one species o f  mussel (Mytilus 
ca lif ornicmus), but acts as a substrate or inhibitor in another species {Mytilus 
galloprovincialis) (Cornwall et al., 1995; Galgani et al., 1996). It remains to be clari­
fied whether such disagreement result from species, tissues, dosage, or other experi­
mental differences.
With the exception o f VIN, a known substrate for pgp, all other xenobiotics 
examined (BNF, BaP, and TCB) have been shown to induce CYP1A in the intestine of 
a number o f fish species (Van Veld et al., 1988a; Van Veld et al., 1988b; Kleinow et 
al., 1998; Doi et al., 2000). The lack o f detectable pgp-related induction in the catfish 
intestine by those CYP1A inducers examined is consistent with a mechanism of pgp 
regulation distinguishable from the Ah receptor pathway, as hypothesized for 
mammalian species (Gant et al., 1991; Schuetz et al., 1995). Because the response of 
pgp to CYP1A inducers have been shown to be inconsistent, more information is 
needed before generalizations regarding the interaction between this two systems can 
be made.
Transport assays utilizing vinblastine (VBL) as a substrate have demonstrated 
contrasting results. The first transport assay demonstrated that intestinal membrane 
vesicles of control and BNF-treated catfish are capable o f VBL transport with classic 
functional MDR characteristics of ATP-dependency and verapamil-sensitivity (Horio 
et al., 1988; Doige and Sharom, 1992). Trends of increased transport following ATP
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addition to the system, as well as decreased transport following VP introduction were 
comparable in both controls and BNF-treated animals. Similar ATP dependency of 
VBL transport was shown to occur in intestinal brush border membrane vesicles of 
adult frogs, which was also inhibited by the addition o f verapamil (Castillo et al., 
1995). Likewise, functional transport of pgp substrates, reversible by addition of pgp 
inhibitors, have been previously described in gill tissues o f aquatic species, including 
snails, mussels, and clams (Cornwall et al., 1995; Kurelec et al., 1995; Waldmann et 
al., 1995; Galgani et al., 1996; Kurelec et al., 1996). Conversely, transport assays 
conducted with a second set of controls and VIN-treated catfish showed no indication 
of VBL transport. Two major methodological differences introduced in the second set 
of experiments may have diminished VBL transport in vesicles. First, it is possible that 
protease inhibitor cocktail used for sample collection may have competitively inhibited 
VBL transport. Evidence has been presented that newly developed protease inhibitors 
are substrates for pgp (Kim et al., 1998; Zhang et al., 1998). Additional studies 
examining individual constituents o f the protease inhibitor cocktail used herein are 
needed to investigate these assumptions. Another possibility is that the commercial 
chow, fed to the animals used in the second transport assays may have interfered with 
pgp-related transport. In vitro studies in rats have shown that transport of the pgp 
substrate etoposide was increased in everted gut sacs pretreated with a natural rodent 
diet, compared to an artificial diet (Lo and Huang, 1999). These results were attributed 
to a possible inhibition o f pgp efflux by flavonoid-related dietary components present 
in natural diets. It is possible that residues o f constituents o f commercial fish feed that
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interfere with pgp-related transport may have affected the functionality of the in vitro 
system used in the present study, but this assumption needs to be further investigated.
The controversy regarding the response o f pgp to xenobiotics suggests that 
protection against xenobiotic toxicity may not be the major or only function of this 
protein. It is likely, however, that pgp is somehow associated to survival, due to its 
highly conserved nature and broad distribution across a variety of species. A physio­
logical function that has been associated with this transporter, which would have 
relevance for aquatic species, is a  role in cell volume regulation, through the activation 
of a chloride channel (Valverde et al., 1992). It appears that cells expressing MDR 
have a faster compensatory response for decreases in cell volume, resulting from 
changes in tonicity, through activation of cell-swelling chloride channels. Another 
pertinent physiological role of pgp is related to peptide transport. There have been 
reports of expression o f half-MDR proteins, assembling as heterodimers, that function 
as a peptide transporter (Bahram et al., 1991). These peptide transporters belong in the 
multidrug-resistance family and share approximately a 30% amino acid sequence 
identity with human MDR1. It is possible that pgp-related transporters in fish may play 
a role in protein absorption. Studies with various teleost species (Noaillac-Depeyre and 
Gas, 1979; Stroband and Kroon, 1981; Lied and Solbakken, 1984) have shown that 
protein absorption by endocytosis occurs in the distal intestine, by a highly developed 
vacuolar system in the epithelial cells. Future investigations of these associations 
would begin to clarify the physiological role of intestinal pgp in aquatic species.
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In summary, immunoblot studies contained herein demonstrate that a protein 
immunochemicaliy related to the mammalian pgp transporter is present in the catfish 
intestine. The intestinal pgp o f catfish has an approximate molecular weight o f 170 
kDa and is very susceptible to degradation. Pgp-related immunoreactivity, as detected 
by immunoblotting, was not apparently altered by the in vivo dietary administration of 
the pgp substrate VIN, or the CYP1A inducers BNF, BaP and TCB. These findings 
have produced conflicting results with previous immunohistochemistry studies, 
suggesting that method sensitivity and pgp localization may be at issue. Functional 
analysis, showing classic MDR characteristics such as energy-dependent and VP- 
sensitive ability of membrane vesicles to transport VBL, suggest that the immunore- 
active protein identified in the catfish intestine is not only immunologically, but also 
functionally related to the mammalian MDR. Furthermore, these studies indicate that 
components in the protease inhibitor cocktail or the commercial diet used herein, may 
inhibit pgp-related transport in intestinal vesicles o f catfish.
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CHAPTER 5: SUMMARY AND CONCLUSIONS
Fish inhabiting polluted environments are exposed to a variety o f  contaminants 
in the diet, including the ubiquitous polychlorinated biphenyls (PCBs). The extent of 
systemic toxic and biochemical effects o f dietary PCBs are directly related to the 
amount o f chemical that is taken up by the consumer. Therefore, the understanding of 
factors that influence the systemic bioavailability o f PCBs from the gastrointestinal 
tract becomes essential in the determination o f the impact of dietary exposures. The 
studies described here examined various factors which would modulate the 
bioavailability o f the coplanar PCB, 3,4,3 \ 4 ’-tetrachlorobiphenyl (TCB) in the 
intestine o f the catfish, including lipid micelle composition, contaminant load, non­
specific toxicity, and intestinal biotransformation, as well as the effect o f TCB upon 
the vectorial transporter p-glycoprotein.
Initial in vitro and in situ experiments demonstrated that micelle fatty acid 
composition affected both the solubility o f  [l4C]-TCB in lipid micelles, as well as the 
bioavailability of [I4C]-TCB from the intestine. These studies indicate that variations 
in fatty acid composition in the intestinal lumen, which will vary according to the fat 
content o f the diet, may greatly affect the extent o f lipophilic contaminants uptake 
from the intestine. These factors are especially relevant for fish species, as seasonal 
variations in temperature and diet have shown to affect constituent fatty acids chain 
length, and even degree of saturation.
Sequential in situ studies demonstrated that a 10-day dietary exposure to TCB 
at either 0.5 or 5 mg/kg diet resulted in equivalent decreases in the systemic
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bioavailability o f  a subsequent [UC]-TCB exposure. These alterations in [I4C]-TCB 
bioavailability appeared to occur from the combined effect o f decreased transport of 
[14C]-TCB to the blood and increased retention in the lumen. One sensible explanation 
for this event would be that tissue accumulation of unlabeled TCB could have altered 
the concentration gradients of [14C]-TCB in comparison to controls, resulting in 
decreased lumen to blood gradient. One interesting finding which may be involved 
with altered transport o f [l4C]-TCB to the systemic circulation, is the significant lower 
intestinal mucosa cytosolic [I4C]-TCB molar equivalent (Meq) values (composite of 
parent [14C]-TCB and metabolites). This observation is consistent with the saturation 
o f unidentified xenobiotic transporters by unlabeled TCB which, in turn, competitively 
decreased the transfer o f [l4C]-TCB to the systemic circulation.
Alterations in systemic bioavailability of [l4C]-TCB following TCB pre- 
exposure did not strictly correlate with alterations in metabolic activities, as 
cytochrome P4501A content and aryl hydrocarbon hydroxylase (AHH) activities were 
induced, but highly variable, only in animals fed the 5 mg TCB/kg dose in vivo. A 
noteworthy finding was that cytochrome P4501A (CYP1A) content correlated in a 
linear fashion to AHH activities, suggesting that the differential CYP1A induction 
seen in the higher TCB dose group was most likely related to differences in the 
amounts and bioavailability of ingested TCB, rather than inhibitory effects, which 
have been reported to occur in other fish species treated with high TCB doses. Another 
interesting feature o f [14C]-TCB intestinal biotransformation was that even though 
single pass metabolism through the intestinal mucosa appeared to be a minor event,
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the predominant metabolites formed (2-OH-3,4,3’,4’-TCB and 4-OH-3,5,3’,4’-TCB) 
differed from profiles described for mammals and the liver o f scup, a fish species. 
These findings indicate that the pathways of [l4C]-TCB metabolism may be different 
in catfish, which would be consistent with previous assumptions that CYP1A probably 
corresponds to a small fraction of total P450 content in the intestine of catfish.
Additional in situ studies utilizing the prototypic CYP1A inducer (5- 
naphthofiavone (BNF) at either 10 or 50 mg BNF/kg diet for 10 days resulted in no 
significant effect on the subsequent systemic bioavailability o f a [l4C]-TCB dose from 
the intestine. These studies further confirmed that metabolism nor histological effect 
played a major role in the modulation of the in situ systemic bioavailability o f [l4C]- 
TCB, as seen with previous TCB preexposures. Additionally, the similarity in the 
histological effects o f dietary BNF to previously seen with TCB exposures indicated 
that this changes were not chemical-specific, and unlikely to have influenced the 
subsequent systemic bioavailability o f [l4C]-TCB. These findings collectively 
supported the assumption that decreases in [l4C]-TCB bioavailability following TCB 
preexposure were diffusion-related.
Studies examining the vectorial transporter p-glycoprotein have showed that 
pgp in the catfish intestine holds structural and functional similarities with pgps 
described in other species. C219 monoclonal antibody crossreactivity with a ~  170 
kJDa protein was seen in immunoblot analysis utilizing membrane vesicles o f intestinal 
mucosa o f catfish. Detection of this protein was complicated by its apparent 
susceptibility to degradation, as to preclude the use o f standard Western Blot
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methodology. In addition, this protein did not appear to be induced by in vivo dietary 
exposures to the pgp inducer vincristine, or the CYP1A inducers TCB, BNF or 
benzo(a)pyrene. These results conflict with previous reports that demonstrated, using 
immunohistochemistry and image analysis, intestinal pgp induction in catfish by some 
of these same compounds. Once again, methodological differences may be at issue. 
Functional analysis indicated that this catfish protein had classic pgp transport 
characteristics, such as ability to accumulate the pgp substrate vinblastine in an ATP- 
dependent, verapamil-sensitive manner. However, transport may be affected by 
protease inhibitors used during tissue processing, or by unidentified compounds in 
commercial fish diets.
In summary, these studies have shown that micelle lipid composition and in 
vivo dietary exposure to TCB played a role in the modulation of the systemic bioavail­
ability o f [l4C]-TCB. [uC]-TCB systemic uptake appears to be affected by a prior 
TCB exposure in a dose-independent fashion, which appears to be unrelated to 
metabolism or CYPlA-related induction. First pass intestinal biotransformation was 
evident, with several hydroxylated metabolites being produced, however, metabolism 
was unrelated to CYP1A induction and was a quantitatively minor event. Prior 
exposure to the CYP1A inducer BNF confirmed that systemic bioavailability o f [l4C]- 
TCB is apparently unrelated to metabolism, or to non-specific toxic effects in the 
intestine. These latter findings support the diffusional character o f the modulation of 
[l4C]-TCB uptake by prior exposure to TCB. Studies with the catfish pgp indicate that
168
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this protein may be functional in the catfish intestine, however, pgp was not responsive 
to dietary TCB, BaP, or BNF under the conditions examined.
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